US5529059A - Inhalation devices - Google Patents
Inhalation devices Download PDFInfo
- Publication number
- US5529059A US5529059A US08/250,060 US25006094A US5529059A US 5529059 A US5529059 A US 5529059A US 25006094 A US25006094 A US 25006094A US 5529059 A US5529059 A US 5529059A
- Authority
- US
- United States
- Prior art keywords
- sealed container
- piercer
- holder
- finely divided
- body member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
- A61M15/0036—Piercing means hollow piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0048—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
- A61M16/122—Preparation of respiratory gases or vapours by mixing different gases with dilution
- A61M16/125—Diluting primary gas with ambient air
- A61M16/127—Diluting primary gas with ambient air by Venturi effect, i.e. entrainment mixers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/105—Filters
- A61M16/106—Filters in a path
- A61M16/107—Filters in a path in the inspiratory path
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Definitions
- This invention relates to devices for the oral or nasal inhalation of finely divided materials, such as medicinal agents and drugs.
- Certain diseases of the respiratory tract are known to respond to treatment by the direct application of medicinal agents.
- medicinal agents are most readily available as a finely divided material, e.g., in dry powdered form, their delivery is most conveniently accomplished by inhaling the finely divided material through the nose or mouth.
- the therapeutic agent in this form may be used for treatment of diseases other than those of the respiratory system.
- the drug When the drug is deposited on the very large surface areas of the respiratory tract, it may be very rapidly absorbed into the blood stream; hence, this method of application may take the place of administration by injection, tablet, or other conventional means.
- U.S. Pat. No. 4,240,418 discloses inhalation devices wherein a container of finely divided material is positioned so that the material from the container can pass by gravity to a delivery area of the device from which it is dispensed. Accordingly, these devices suffer the disadvantage that the user must maintain the device in a particular position so that the finely divided material can pass by gravity to the collecting plate and is not dislodged therefrom prior to dispensing. It appears that such devices also require a large dispensing passage to prevent interference with the free fall of a relatively large load of the finely divided material.
- Some known inhalation devices use members which vibrate to dispense the finely divided material, thus increasing the complexity and bulk of the device.
- the devices of U.S. Pat. No. 3,948,264 utilize batteries to activate vibrators.
- Other devices incorporate breath activated vibratable members to disperse the finely divided materials. See, e.g., U.S. Pat. Nos. 3,888,253 and 4,995,385 which include a member which vibrates in the airflow to dispense the finely divided material.
- Still other known devices use a breath activated propeller device to spin the container of finely divided material, thereby casting the material out by centrifugal force, e.g., U.S. Pat. No. 3,507,277. A relatively high velocity of air flow is required to activate such devices, again a problem for breath impaired users.
- inhalation devices e.g., conventional aerosol bronchodilators
- drug delivery is achieved by the sometimes difficult coordination of digital force with voluntary inhalation.
- Devices of the present invention utilize air flow through a container of finely divided material, the container having one section open to the atmosphere and another open to the interior of the device, to dispense the finely divided material.
- air As air is drawn through the container and the device by oral or nasal inhalation of the user, increased air velocity causes decreased pressure within the device. This results in a pressure differential between the section of the container open to the atmosphere and the section open to the body member.
- the resultant flow of air from outside atmospheric pressure to inside partial vacuum picks up the finely divided material carrying it into the device to mix with the internal flow of air.
- the passage of air through the container of finely divided material, and the device virtually purges the material from both the container and the device, thereby carrying it along with the user's inspired breath to the lungs or nasal passages.
- the inhalation devices of the present invention overcome many of the disadvantages associated with known devices.
- One important advantage resides in their ability to accurately and repeatedly disperse the finely divided material. Because it is air flow through the finely divided material that causes dispensing, the air flow through the container typically causes virtually all of the finely divided material to be evacuated.
- Another advantage of devices in accordance with the present invention is that loads of finely divided material as low as about 0.1 mg can be dispensed. This is also an important advantage because by dispensing small doses of finely divided materials, such as pharmaceuticals, the use of fillers, such as lactose, is minimized.
- Yet another major advantage of inhalation devices in accordance with the present invention is the total protection of the finely divided material up to the moment of use.
- Each individual dose is hermetically sealed, in some cases removably hermetically sealed, to assure as long a shelf life as possible and freedom from contamination.
- the present inhalation devices require little or no coordination on the part of the user, since inhalation of breath causes the device to function.
- the user need only press down on a conveniently located button to perforate the container of finely divided material to ready the device for use.
- the finely divided material remains in the container until activated by patient inhalation which can occur within any reasonable time period after the container seal is broken.
- a relatively low velocity of air flow through the body member is adequate to achieve full dispensing, generally even for a child.
- the inhalation devices of the present invention have the further advantage of great simplicity which renders them capable of being made in a small size for inconspicuous portability, further enhancing the desirability for use as a personal dispenser.
- One preferred inhalation device of the present invention is pen-like in design to render it easy to use inconspicuosly, as well as to provide other important advantages.
- the devices disclosed herein are adapted for receiving from a single to multiple containers of finely divided material.
- the device is adapted to receive a circular disk containing multiple containers of finely divided material. Not only does this embodiment provide a convenience for the user, it also provides an economy in production filling.
- One inhalation device in accordance with the present invention comprises (i) a body member having an air passageway therethrough, one end of the body member being adapted for insertion into the mouth or nose of the user; (ii) a holder connected to the body member for receiving at least one removably sealed container of finely divided material; and (iii) at least one piercer for piercing the removably sealed container while the sealed container is in the holder, the piercer extending from the body member and into the holder and having a passageway therethrough open to the body member and the holder.
- a removably sealed container is placed in the holder thereby causing the piercer to pierce the sealed container.
- the removable seal is then removed and air drawn through the unsealed and pierced container, the piercer, and the body member cooperate to cause finely divided material disposed in the container to be dispensed therefrom.
- the piercer extends from the body member through the holder for a distance greater than the dimension of the sealed container to be pierced, thus, providing devices for the oral or nasal inhalation of finely divided materials from a sealed container which need not be provided with a removable seal.
- the dimensions of the piercer are such that when the sealed container is placed in the holder thereby causing the piercer to pierce through the sealed container therein, the finely divided material is transferred from the container to the air passageway of the piercer as it passes through the container. Subsequently, air drawn through the piercer and the air passageway of the body member cooperate to cause the finely divided material disposed in the piercer to be dispensed therefrom.
- the present invention provides yet another inhalation device for dispensing finely divided materials from a sealed container which is not provided with a removable seal.
- Such devices typically include at least two piercers and comprise: (i) a body member having an air passage therethrough, one end of the body member being adapted for insertion into the mouth or nose of the user; (ii) a holder for receiving at least one sealed container of finely divided material, the holder being connected to the body member; (iii) at least one first piercer for piercing the sealed container while in the holder, the first piercer extending into the interior of the holder and having an air passageway therethrough open to the body member and the holder; (iv) at least one second piercer for piercing the sealed container while in the holder, the second piercer extending into the holder and having a air passageway therethrough, open to the interior and exterior of the holder; and (v) engaging means for causing the first and second piercer, while the sealed container is in the
- These devices operate so that when the sealed container is positioned in the holder and the engaging means causes the first and second piercers to pierce the sealed container to create an air passageway therethrough, air drawn through the first piercer, the pierced container, the second piercer, and the passageway of the body member cooperate to cause finely divided material disposed in the pierced container to be dispensed therefrom.
- FIG. 1 is an perspective view of one embodiment of a device in accordance with the present invention.
- FIG. 2 is an perspective view of another embodiment of a device according to the present invention.
- FIG. 3A is a section on line 3A-3A of the device shown in FIG. 1, showing a cross-section of a container of finely divided material disposed therein, wherein the removable seal has been removed.
- FIG. 3B is an end view of the device shown in FIG. 1.
- FIG. 3C is a plan view of the device shown in FIG. 1.
- FIG. 4 is cross-sectional view of yet another embodiment of a device of the present invention, similar to that shown in FIG. 3.
- FIG. 5 is an enlarged cross-sectional view of the removably sealed container of finely divided material shown in FIG. 3A wherein the removable seal is intact.
- FIG. 6A is a cross-sectional view of the device shown in FIG. 2 taken along line 6A--6A of FIG. 2A.
- FIG. 6B is an end view of the device shown in FIG. 2 showing the inhalation end.
- FIG. 6C is an end view of the device shown in FIG. 2 showing the air intake end.
- FIG. 6D is a plan view of the device shown in FIG. 2.
- FIG. 7A is a plan view of a disk provided with multiple sealed containers containing finely divided materials for use in the present invention.
- FIG. 7B is a side view of the disk shown in FIG. 7A.
- FIG. 7C is a bottom view of the disk shown in FIG. 7A.
- FIG. 8 is a cross-sectional view of another device in accordance with the present invention, showing a cross-sectional view of a tapered container.
- FIGS. 9A-9D are cross-sectional views of yet other devices in accordance with the present invention.
- FIG. 10 is a graph showing total excretion of free H 3 -cortisol for a 24 hour period after administration nasally in accordance with the present invention as compared with excretion of free H 3 cortisol after conventional oral administration.
- FIG. 11 is a graph showing excretion of free H 3 -cortisol over a 24 hour period after administration nasally in accordance with the present invention as compared with excretion of free H 3 cortisol after conventional oral administration.
- inhalation devices of the present invention are primarily illustrated by means of devices which have been adapted for oral inhalation, it will be appreciated by those skilled in the art that such devices may also be adapted for nasal inhalation of finely divided materials.
- FIGS. 1 and 3 there is shown one embodiment of an inhalation device of the present invention for the oral inhalation of finely divided materials from a removably sealed container.
- the device shown comprises a body member 20 having an air passageway 22 therethrough, the air passageway comprising a venturi.
- One end 24 of the body member 20 is adapted for insertion into the mouth of the user.
- the other end 27 is an air intake end and may optionally be provided with a screen (not shown) to filter inhaled air.
- a holder 40 comprising an open receptacle for receiving at least one removably sealed container 60 of finely divided material 64, is connected to body member 20.
- At least one piercer 26 (shown in FIG.
- the piercer 26 has a passageway therethrough open to the body member 20 and the holder 40.
- the container 60 is dimensioned to extend above the holder 40 while present therein so that the user can access the removable seal 62 and can grasp and remove the container 60 after use.
- An enlarged cross-sectional view of a removably sealed container is shown in in FIG. 5.
- the removably sealed container 60 is placed in the holder 40 thereby causing the piercer 26 to pierce the sealed container 60 and to hold the tab of sealing material 66 created thereby (See, e.g., FIG. 5) against the container 40.
- the removable container seal 62 is then removed, thereby creating an opening to the atmosphere.
- the device shown in FIG. 4 is similar to that shown in FIG. 3. However, it is adapted for use in conjunction with a sealed container which is not provided with a removable seal.
- the piercer 26 in this device extends from the body member 20 through the holder 40 for a distance greater than the dimension of the sealed container 60 to be pierced.
- the sealed container 60 is placed in the holder 40 as shown in FIG. 4, thereby causing the piercer 26 to pierce through the sealed container 60, the finely divided material 64 is transferred from the container 60 to the air passageway of the piercer 26 from which it is dispensed upon inhalation by the user.
- the mouthpiece 24 of the inhalation devices of the present invention is placed inside the lips of the user to minimize impingement of the finely divided material on the mouth.
- a quick intake of breath causes air to flow through the air intake end 27 and into air passageway 22 of body member 20 to create a partial vacuum, thereby causing the finely divided material 64 to be dispersed from (i) the pierced and unsealed container 60 in the embodiment showing in FIGS. 1,3, and 9; and (ii) from the air passageway of the piercer 26 in the embodiment shown in FIG. 4.
- FIGS. 2 and 6 Another preferred device in accordance with the present invention, shown in FIGS. 2 and 6, comprises a body member 20 having an air passageway 22 therethrough, and a holder 40.
- One end 24 of the body member 20 is adapted for insertion into the mouth of the user.
- the other end 27, the air intake end, of body member 20 is provided with a screen 28 to minimize inhalation of undesired materials, e.g., dust, which may be present in the air.
- a first piercer 26 for piercing the sealed container 60 while in the holder 40 extends into the interior of the holder 40 and has a passageway therethrough open to the body member 20 and the holder 40.
- the holder 40 is adapted to receive a disk 70 provided with multiple containers 60 as shown in FIG. 7.
- the holder 40 comprises a receptacle 42 fixed to the body member 20 and a cover 44 movably attached to receptacle 42 by hinge means 46.
- the disk 70 while in the holder 40 is rotably, centrally disposed on a pin (not shown) which is mounted therein.
- the disk 70 is provided with a conventional locking means so that during rotation, the disk is locked in position each time a container of finely divided material is disposed adjacent piercers 26, 52, thereby locating each single dose container 60 for dispensation.
- Disks of a given diameter can contain different numbers of single doses depending upon the requirements of the particular drug in use.
- one inhalation device in accordance with the present invention can have many different drug applications.
- a preferred multiple cavity disk 70 is about 0.75 to 1.25 inches in diameter, about 0.250 to 0.312 inches deep and is provided with individual sealed containers, similar to those shown in FIG. 5.
- the disk 70 is typically made of conventional molded plastics, such as, polypropylene, polyethylene, acetal, ABS and so forth. However, other conventional materials known to those skilled in the art may also be used.
- disk 70 can be rotated mechanically after use, for simplicity the preferred method is hard rotation. It will be apparent to those skilled in the art that the disk 70 could be replaced with multiple container strips, either rigid or in flexible rolls, e.g., as in cartridge belt for an automatic weapon, and so forth.
- the cover 44 is provided with perforations 45 to provide an opening to the atmosphere through which air is drawn upon inhalation by the user when the pierced container 60 is in the device.
- the cover is also provided with a section 48 having a first leaf spring 50. Section 48 is movably mounted in the cover 44, flanges 49 providing stops to maintain section 48 in cover 44, when cover 44 is raised to insert a disk 70 of sealed containers 60.
- a second piercer 52 mounted in cover section 48 extends into the interior of the holder 40 and has a passageway therethrough open at both ends to the holder 40.
- the second piercer 52 is positioned relative to the first piercer 26 so that they are capable of cooperating to pierce the sealed container 60 when the sealed container 60 is in receptacle 42 and rotated into dispersing position adjacent piercers 26, 50.
- Receptacle 42 is provided with a second leaf spring 51 disposed between body member 20 and disk 70, when the disk 70 is in holder 40.
- the movable cover section 48 cooperates with leaf springs 50, 51 to provide the engaging means for causing the first and second piercers 26, 52 to pierce the sealed container 60 while in the holder 40 when movable cover section 48 is pressed towards container 60 by the user.
- the movable cover section 48 is depressed by the user so that piercers 26 and 52 pierce the seals 61 (shown in FIG. 5) of the container 60 of finely divided material 64, thereby creating an air passage.
- the air passage is blocked only by the finely divided material 64, because the tab of pierced seal 66 is held against the side of holder 40 by piercer 26 (See FIG. 5).
- the movable cover section 48 is held in a depressed position until after inhalation by the user so that the piercers 52, 26 will remain in contact with the container 60 of finely divided material 64.
- the passage of air through the perforation in seal 62, needle 52, container 60, needle 26, and air passageway 22 virtually purges the finely divided material 64 from the container 60, carrying it along with the patients inspired breath into the lungs.
- the air passageway 22 of the body member 20 comprises a venturi or a tube, wherein the first piercer 26 is disposed at or adjacent the smallest diameter of the venturi or the midpoint of the tube.
- a venturi is a particularly preferred configuration for the air passageway 22 of the body member as shown, e.g., in FIGS. 3A, 4, 6A and 8.
- the body member 20 has a major diameter at each end ("B" in FIG. 6A) about 0.3 to 0.8 inches with, in the case of embodiments wherein the air passageway 22 composes a venturi, a minor diameter ("A" in FIG. 6A) at the venturi's point of restriction 23 of about 0.2 to 0.5 inches.
- A minor diameter
- the inner diameter (“D" in FIG. 6A) of holder 40 is dimensioned to receive disk 70 and may be from about 0.5 to 1.5 inches when A and B have the dimensions set forth above. It is understood that the circumstances of use will dictate the dimensions without altering the intent of the device. For example, one might wish the unit to resemble a pocketable pen as shown in FIG. 8 to achieve an enhanced degree of portability.
- the relative dimensions of the containers of finely divided material for use in the devices of the present invention and the piercer(s) of such devices are selected to provide accurate delivery of the finely divided material.
- the dimensions of the piercer 26 which opens to body member 20, as well as the end or ends of the container 60 pierced thereby, are selected to minimize entrapment of the finely divided material 64 adjacent piercer 26.
- Finely divided material below the orifice of the needle 26 is unlikely to evacuate, yet the needle 26 must project high enough to hold tab 66 (shown in FIG. 5) in a vertical position. If tab 66 is not held parallel to the sides of the container, it may be drawn down by the vacuum created upon inhalation to seal off piercer 26, thereby upsetting dosage accuracy.
- the diameter of the cylindrical container is stepped down at the end disposed adjacent piercer 26 while in the device, to minimize entrapment of the finely divided material. See, e.g., stepped down section 69 in FIG. 5.
- the step is preferably equal in length to the outside diameter of piercer 26 (i.e., about the size of tab 66 in the vertical position).
- the dimensions of piercer 52 are not as important since the tab created by piercer 52 is not positioned so that it will interfere with dispensing of the finely divided material. However, piercer 52 must be sufficiently large to permit unobstructed flow of air.
- the inhalation devices of the present invention shown in the figures embody a piercer 26 which comprises a needle, preferably sharpened at the piercing end to about a 30° to 45° angle.
- the rim of the needle opposite the apex of the needle point is typically blunted to avoid cutting a piece of the seal 61 of container 60 free. As shown in FIG. 5, this leaves a tab 66 of the seal "hinged" to the container 60 thereby preventing ingestion.
- the needle 26 has an inner diameter of about 0.01 to 0.15 inches and an outer diameter of about 0.03 to 0.170 inches.
- Such inside diameters afford adequate flow of finely divided material while still retaining it in the container 40 until the moment of discharge.
- diameters outside the preferred ranges may be useful, depending in part upon the fluidity of the finely divided material. For example, a highly fluid finely divided material would call for a smaller diameter needle 26 than less fluid material in order to hold the powder inside the container 40 until evacuated by the inhalation of the user.
- the needle 26 extends into the container 60 for approximately one needle diameter length, plus the length of the sharpened angle, or sufficiently far to hold tab 66 in a position generally parallel to the side of the needle 26 and adjacent the inner wall of the container 40, thereby leaving a clear passage for air flow. This enables tab 66 to remain attached to the container 40 and to be bent to a position as shown in FIG. 5.
- the needle 26 preferably has an inner diameter of about 0.01 to 0.15 inches and an outer diameter of about 0.03 to 0.170 inches
- section 69 of the container has an inner diameter of about 0.180 to inches
- section 68 has a diameter of about 0.045 to about 0.190 inches.
- piercer 26 has an inner diameter of about 0.045 inches and an outer diameter of about 0.062 inches and the section 68 of container 60 has an inner diameter of about 0.070 inches and section 69 has an inner diameter of about 0.080 inches.
- the second piercer 52 is also preferably sharpened at the piercing end to about a 30° to 45° angle and the rim opposite the apex of the point is typically blunted.
- the inner diameter of piercer 52 is typically about 10 to 15% greater than the inner diameter of piercer 26.
- leaf springs 50 and 51 are preferably stainless steel and are about 0.005 to 0.015 inches, more preferably about 0.010 to 0.012 inches. Molded plastic springs can also be used but the extra thickness of such springs may be undesirable.
- the container is preferably cylindrical.
- the diameter of the container 60 is constant throughout, e.g., as shown in FIG. 4.
- the container is provided with a first section 68 and a second section 69, narrower in diameter than section 68, as shown in, e.g., FIG. 5.
- section 68 of container 60 tapers outwardly. This taper allows a greater volume of finely divided material to be loaded within a given depth. For proper evacuation of the container 60, the taper should not exceed an angle of about 10° to 15°.
- the inner diameter of section 68 of the container 60 is about 10 to 15% larger than the outer diameter of needle 26.
- the inner diameter of the container is only about 10 to 15% larger than the outer diameter of needle 26 to minimize any residue of finely divided material which may be left behind in the container.
- the amount and fluidity of the finely divided material to be delivered will in large part determine the dimensions of the inhalation devices of the present invention.
- the devices of the present invention are capable of delivering amounts of finely divided material ranging from about 0.1 to 25 milligrams.
- containers of the finely divided material for use in the present invention are also adapted for the particle size and amount of such material to be dispensed and, preferably, are large enough to provide an empty space 65 above the surface of the finely divided material. See, e.g., FIG. 5.
- This space 65 allows the finely divided material 64 to remain loose, avoiding agglomeration in storage and compaction from pressure as the needle 26 penetrates the container 60.
- the container 60 is about half filled with finely divided material 64.
- the particle size of the finely divided material to be delivered also influences the dimensions of the devices of the present invention.
- the desired particle size is determined, in part, by the mode of delivery, i.e., orally or nasally.
- the intent is to get the greatest possible portion of the dose of finely divided material into the lungs and to avoid impingement on the lining of the buccal cavity.
- nasal administration it is desirable to have the major portion of the powder dose deposited on the nasal mucosa and the minimum amount carried to the lungs.
- a finer particle size and greater flow of air through the device of the present invention is used in oral delivery as compared with nasal delivery to accomplish the desired end. It is believed that the minimum air flow that would discharge the powder fully would also minimize the amount of powder carried to the lungs for nasal applications.
- Containers for use in the present invention are sealed at one or both ends with a conventional piercable material, such as a plastic or metal film, using methods known to those skilled in the art. See, e.g., film 61 in FIG. 5.
- a conventional piercable material such as a plastic or metal film
- the thickness of the film is about 0.002 to 0.004 inches.
- the desired characteristics for such sealing materials are high tensile strength to avoid tearing during perforation and resistance to the passage of moisture.
- a polyester film having heat activating adhesive on one side is used to seal the containers.
- polyester is preferred, other films known in the art, such as aluminum foil, may also be employed.
- the removable seal comprises a hermetic foil seal which is provided with an integral tab for ease of manual removal.
- the disk 70 is typically first sealed on one side with a piercable sealing material.
- the finely divided material 64 to be dispensed is then added to the multiple containers 60 disposed in disk 70 and the containers 60 are then hermetically sealed by sealing the other side of disk 70 either with a removable seal or with piercable sealing material.
- the devices and containers of the present invention are made from conventional materials and by conventional techniques known to those of ordinary skill in the art. To ensure simple manufacture of such devices and containers, it is advantageous to use a readily processable plastic where suitable.
- holder 40 may be connected to the body member 20 at various angles as illustrated in FIG. 9: FIG. 9A showing a 45° angle, FIGS. 9B and 9C a 90° angle, and FIG. 9D a 30° angle.
- body member 20, holder 40, and piercers 26 and 52 are arranged in parallel, i.e., at 0° angle.
- the embodiment shown in FIG. 8 is pocketable and less conspicuous in use, being somewhat pen-like in appearance.
- the cover 44 of the embodiment shown in FIG. 8 is removed, the sealed container 60 is inserted in the holder 40, and the bottom seal of container 60 is pierced. The cover 44 is replaced and pressed home to pierce the top seal. After removing the dust cap 54, the user places the mouthpiece 24 in the mouth and inhales.
- the dimensions are as follows: overall length, about 3 to 6 inches; diameter, about 0.25 to 0.75 inches; length of body member 20, about 2 to 4 inches; length of cover 44, about 1.5 to 2.5 inches; length of piercer 26, about 1 to 1.75 inches; and length of piercer 52, about 0.375 to 0.75 inches.
- the breath required for actuation of the device was only about 25 liters per minute.
- the dimensions of this device were as follows: overall length of about 3.375 inches; an inside diameter of about 0.32 inches at the widest section and 0.25 inches at the narrowest section of the venturi; body member 20 length of about 2.25 inches; holder 40 length of about 0.375 inches; piercer 26 length of about 1.1 inches; and piercer 52 length of about 0.5 inches.
- the internal diameter is reduced to restrict the air flow for delivery.
- the narrowest section of the venturi can be reduced to about 0.187 inches in diameter to restrict the air flow.
- end 24 of the body member 20 is adapted to fit the human nose, and in some such embodiments, is bent upward at a 30° angle for comfort in use.
- the basic dimensions are similar to those given above.
- H 3 -cortisol cortisol tritiated (H 3 -cortisol) using an inhalation device similar to that shown in FIGS. 1 and 3A was compared with conventional oral administration of H 3 -cortisol by testing the urine of recipients of the H 3 -cortisol for its presence.
- Free, unmetabolized H 3 -cortisol present in the urine reflects the amount of H 3 -cortisol in circulation.
- free cortisol cortisol which has not been altered by the liver. It is known that when cortisol is ingested, a good portion is inactivated or metabolized in the liver.
- FIG. 10 shows that more free H 3 -cortisol was excreted in a 24 hour period in the urine when the H 3 cortisol was administered via an inhalation device of the present invention as compared with ingestion.
- FIG. 11 shows that inhaled cortisol is more directly available for excretion in the urine at an earlier time than is ingested cortisol.
- FIGS. 1 and 3A A device similar to that shown in FIGS. 1 and 3A was tested to determine its delivery accuracy.
- a container similar to that shown in FIGS. 3A and 5 was filled with about 3.24 mg of finely divided material and placed in the holder 40 of a device similar to that shown in FIGS. 1 and 3A. It was not necessary to provide the container with a removeable seal 62 because the finely divided material was dispensed immediately after being placed in the container.
- the method of discharge was by hand vacuum pump with a volume approximately equal to the human lung. A constant stroke was used in dispensing to minimize variation.
- the container was removed from the device and weighed again, and the residue of finely divided material determined. This process was repeated thirty-five times. The container was virtually purged with each delivery, and the residue remaining was very constant and very small. Thus, very accurate dose delivery was achieved by the use of a device of the present invention.
- H 3 -cortisol for inhalation and for oral ingestion was prepared as follows: 100 mg of cortisol was weighed in a clean crucible. 200 m ⁇ of H 3 -cortisol dissolved in ethanol was added to the powder, and thereafter, the ethanol was evaporated in a desiccator and the sample mixed well. The mixture of unlabelled and H 3 -cortisol was ground with a stainless steel spoon shaped spatula. 5 mg of this mixture was weighed on glassene paper and then placed in a vial containing 0.5 ml of water and 5.0 ml of pico-fluor. Approximately 6,523,223 counts per minute/5 mg was prepared, giving a specific activity for H 3 -cortisol of 1,279,063 counts/minute/mg.
- FIG. 10 demonstrates that of the total counts per minute excreted, for a 24 hour period the percent as free H 3 -cortisol was approximately 25% for the inhaled dose and less than 5% for the ingested dose.
- FIG. 11 shows counts per minute of free H 3 -cortisol excreted over a 24 hour period for both oral ingestion and inhalation of the same dose. It can be seen that there was an early rise in counts per minute of free H 3 -cortisol after inhalation which is not observed in the urine of an individual after oral ingestion of the labeled cortisol.
Abstract
The present invention provides devices for the oral or nasal inhalation of finely divided materials such as medicinal agents and drugs.
Description
This is a continuation of application Ser. No. 07/738,924 filed on Aug. 1, 1991, now U.S. Pat. No. 5,337,740.
This invention relates to devices for the oral or nasal inhalation of finely divided materials, such as medicinal agents and drugs.
Certain diseases of the respiratory tract are known to respond to treatment by the direct application of medicinal agents. As many such agents are most readily available as a finely divided material, e.g., in dry powdered form, their delivery is most conveniently accomplished by inhaling the finely divided material through the nose or mouth. This results in better utilization of the medicinal agent in that it is deposited exactly at the site desired and where its action may be required; hence, very minute doses of the therapeutic agent are often equally as efficacious as larger doses administered by other means, with a consequent marked reduction in the incidence of undesired side effects. Alternatively, the therapeutic agent in this form may be used for treatment of diseases other than those of the respiratory system. When the drug is deposited on the very large surface areas of the respiratory tract, it may be very rapidly absorbed into the blood stream; hence, this method of application may take the place of administration by injection, tablet, or other conventional means.
A variety of inhalation devices for the delivery of finely divided materials are known in the art. For example, U.S. Pat. No. 4,240,418 discloses inhalation devices wherein a container of finely divided material is positioned so that the material from the container can pass by gravity to a delivery area of the device from which it is dispensed. Accordingly, these devices suffer the disadvantage that the user must maintain the device in a particular position so that the finely divided material can pass by gravity to the collecting plate and is not dislodged therefrom prior to dispensing. It appears that such devices also require a large dispensing passage to prevent interference with the free fall of a relatively large load of the finely divided material.
Other known inhalation devices incorporate a deflector (U.S. Pat. No. 4,098,273) or a hollow tube (U.S. Pat. No. 3,938,516) to divert air flow into a chamber to dislodge the finely divided material, thereby requiring a substantial flow of air to disperse the finely divided material. Inhalation sufficient to create such a substantial flow of air is difficult for some users, e.g., asthmatics. Furthermore, it is believed that such devices deliver somewhat imprecise doses due to the inevitable variations in residue of finely divided material left behind in the container after dispensing.
Some known inhalation devices use members which vibrate to dispense the finely divided material, thus increasing the complexity and bulk of the device. For example, the devices of U.S. Pat. No. 3,948,264, utilize batteries to activate vibrators. Other devices incorporate breath activated vibratable members to disperse the finely divided materials. See, e.g., U.S. Pat. Nos. 3,888,253 and 4,995,385 which include a member which vibrates in the airflow to dispense the finely divided material. Still other known devices use a breath activated propeller device to spin the container of finely divided material, thereby casting the material out by centrifugal force, e.g., U.S. Pat. No. 3,507,277. A relatively high velocity of air flow is required to activate such devices, again a problem for breath impaired users.
Moisture in most powders tends to cause agglomeration and clumping thereby inhibiting the breakup and dispersion of the finely divided medication, an essential step in effective dispensing of the material. However, the manner in which many known devices operate renders hermetic sealing of the container of finely divided material impossible. In still other known devices, the containers for finely divided materials are gelatin capsules which are susceptible to atmospheric moisture.
In some known inhalation devices, e.g., conventional aerosol bronchodilators, drug delivery is achieved by the sometimes difficult coordination of digital force with voluntary inhalation.
New and more potent drugs which can be used in increasingly small quantities are being developed on an ongoing basis. In most instances, known inhalation devices for finely divided materials are not capable of delivering such small quantities without the addition of a significant amount of filler. It is highly desirable to minimize the use of such fillers, e.g., in order to reduce the likelihood of side effects.
It can be seen that presently known devices for the delivery of finely divided materials suffer disadvantages which include imprecise delivery, inability to deliver directly from a hermetically sealed container, high breath demands upon the user, limited portability due to bulk, and complexity of design. Thus, alternative inhalation devices are being sought.
Devices of the present invention utilize air flow through a container of finely divided material, the container having one section open to the atmosphere and another open to the interior of the device, to dispense the finely divided material. As air is drawn through the container and the device by oral or nasal inhalation of the user, increased air velocity causes decreased pressure within the device. This results in a pressure differential between the section of the container open to the atmosphere and the section open to the body member. The resultant flow of air from outside atmospheric pressure to inside partial vacuum picks up the finely divided material carrying it into the device to mix with the internal flow of air. The passage of air through the container of finely divided material, and the device virtually purges the material from both the container and the device, thereby carrying it along with the user's inspired breath to the lungs or nasal passages.
The inhalation devices of the present invention overcome many of the disadvantages associated with known devices. One important advantage resides in their ability to accurately and repeatedly disperse the finely divided material. Because it is air flow through the finely divided material that causes dispensing, the air flow through the container typically causes virtually all of the finely divided material to be evacuated. Another advantage of devices in accordance with the present invention is that loads of finely divided material as low as about 0.1 mg can be dispensed. This is also an important advantage because by dispensing small doses of finely divided materials, such as pharmaceuticals, the use of fillers, such as lactose, is minimized.
Yet another major advantage of inhalation devices in accordance with the present invention is the total protection of the finely divided material up to the moment of use. Each individual dose is hermetically sealed, in some cases removably hermetically sealed, to assure as long a shelf life as possible and freedom from contamination.
Furthermore, the present inhalation devices require little or no coordination on the part of the user, since inhalation of breath causes the device to function. In one embodiment, the user need only press down on a conveniently located button to perforate the container of finely divided material to ready the device for use. The finely divided material remains in the container until activated by patient inhalation which can occur within any reasonable time period after the container seal is broken. Moreover, a relatively low velocity of air flow through the body member, as measured by a standard flow meter, is adequate to achieve full dispensing, generally even for a child.
The inhalation devices of the present invention have the further advantage of great simplicity which renders them capable of being made in a small size for inconspicuous portability, further enhancing the desirability for use as a personal dispenser. One preferred inhalation device of the present invention is pen-like in design to render it easy to use inconspicuosly, as well as to provide other important advantages.
The devices disclosed herein are adapted for receiving from a single to multiple containers of finely divided material. In one preferred embodiment, the device is adapted to receive a circular disk containing multiple containers of finely divided material. Not only does this embodiment provide a convenience for the user, it also provides an economy in production filling.
One inhalation device in accordance with the present invention comprises (i) a body member having an air passageway therethrough, one end of the body member being adapted for insertion into the mouth or nose of the user; (ii) a holder connected to the body member for receiving at least one removably sealed container of finely divided material; and (iii) at least one piercer for piercing the removably sealed container while the sealed container is in the holder, the piercer extending from the body member and into the holder and having a passageway therethrough open to the body member and the holder. A removably sealed container is placed in the holder thereby causing the piercer to pierce the sealed container. The removable seal is then removed and air drawn through the unsealed and pierced container, the piercer, and the body member cooperate to cause finely divided material disposed in the container to be dispensed therefrom.
In another similar embodiment of the present invention, the piercer extends from the body member through the holder for a distance greater than the dimension of the sealed container to be pierced, thus, providing devices for the oral or nasal inhalation of finely divided materials from a sealed container which need not be provided with a removable seal. In such embodiments, the dimensions of the piercer are such that when the sealed container is placed in the holder thereby causing the piercer to pierce through the sealed container therein, the finely divided material is transferred from the container to the air passageway of the piercer as it passes through the container. Subsequently, air drawn through the piercer and the air passageway of the body member cooperate to cause the finely divided material disposed in the piercer to be dispensed therefrom.
The present invention provides yet another inhalation device for dispensing finely divided materials from a sealed container which is not provided with a removable seal. Such devices typically include at least two piercers and comprise: (i) a body member having an air passage therethrough, one end of the body member being adapted for insertion into the mouth or nose of the user; (ii) a holder for receiving at least one sealed container of finely divided material, the holder being connected to the body member; (iii) at least one first piercer for piercing the sealed container while in the holder, the first piercer extending into the interior of the holder and having an air passageway therethrough open to the body member and the holder; (iv) at least one second piercer for piercing the sealed container while in the holder, the second piercer extending into the holder and having a air passageway therethrough, open to the interior and exterior of the holder; and (v) engaging means for causing the first and second piercer, while the sealed container is in the holder, to pierce the sealed container.
These devices operate so that when the sealed container is positioned in the holder and the engaging means causes the first and second piercers to pierce the sealed container to create an air passageway therethrough, air drawn through the first piercer, the pierced container, the second piercer, and the passageway of the body member cooperate to cause finely divided material disposed in the pierced container to be dispensed therefrom.
In the drawings:
FIG. 1 is an perspective view of one embodiment of a device in accordance with the present invention.
FIG. 2 is an perspective view of another embodiment of a device according to the present invention.
FIG. 3A is a section on line 3A-3A of the device shown in FIG. 1, showing a cross-section of a container of finely divided material disposed therein, wherein the removable seal has been removed.
FIG. 3B is an end view of the device shown in FIG. 1.
FIG. 3C is a plan view of the device shown in FIG. 1.
FIG. 4 is cross-sectional view of yet another embodiment of a device of the present invention, similar to that shown in FIG. 3.
FIG. 5 is an enlarged cross-sectional view of the removably sealed container of finely divided material shown in FIG. 3A wherein the removable seal is intact.
FIG. 6A is a cross-sectional view of the device shown in FIG. 2 taken along line 6A--6A of FIG. 2A.
FIG. 6B is an end view of the device shown in FIG. 2 showing the inhalation end.
FIG. 6C is an end view of the device shown in FIG. 2 showing the air intake end.
FIG. 6D is a plan view of the device shown in FIG. 2.
FIG. 7A is a plan view of a disk provided with multiple sealed containers containing finely divided materials for use in the present invention.
FIG. 7B is a side view of the disk shown in FIG. 7A.
FIG. 7C is a bottom view of the disk shown in FIG. 7A.
FIG. 8 is a cross-sectional view of another device in accordance with the present invention, showing a cross-sectional view of a tapered container.
FIGS. 9A-9D are cross-sectional views of yet other devices in accordance with the present invention.
FIG. 10 is a graph showing total excretion of free H3 -cortisol for a 24 hour period after administration nasally in accordance with the present invention as compared with excretion of free H3 cortisol after conventional oral administration.
FIG. 11 is a graph showing excretion of free H3 -cortisol over a 24 hour period after administration nasally in accordance with the present invention as compared with excretion of free H3 cortisol after conventional oral administration.
Although the inhalation devices of the present invention are primarily illustrated by means of devices which have been adapted for oral inhalation, it will be appreciated by those skilled in the art that such devices may also be adapted for nasal inhalation of finely divided materials.
Referring now to FIGS. 1 and 3 there is shown one embodiment of an inhalation device of the present invention for the oral inhalation of finely divided materials from a removably sealed container. The device shown comprises a body member 20 having an air passageway 22 therethrough, the air passageway comprising a venturi. One end 24 of the body member 20 is adapted for insertion into the mouth of the user. The other end 27 is an air intake end and may optionally be provided with a screen (not shown) to filter inhaled air. A holder 40, comprising an open receptacle for receiving at least one removably sealed container 60 of finely divided material 64, is connected to body member 20. At least one piercer 26 (shown in FIG. 3A) for piercing the removably sealed container 60, while the sealed container 60 is in the holder 40, extends from the body member 20 and into the holder 40. The piercer 26 has a passageway therethrough open to the body member 20 and the holder 40.
The container 60 is dimensioned to extend above the holder 40 while present therein so that the user can access the removable seal 62 and can grasp and remove the container 60 after use. An enlarged cross-sectional view of a removably sealed container is shown in in FIG. 5. In use, the removably sealed container 60 is placed in the holder 40 thereby causing the piercer 26 to pierce the sealed container 60 and to hold the tab of sealing material 66 created thereby (See, e.g., FIG. 5) against the container 40. The removable container seal 62 is then removed, thereby creating an opening to the atmosphere.
The device shown in FIG. 4 is similar to that shown in FIG. 3. However, it is adapted for use in conjunction with a sealed container which is not provided with a removable seal. The piercer 26 in this device extends from the body member 20 through the holder 40 for a distance greater than the dimension of the sealed container 60 to be pierced. When the sealed container 60, is placed in the holder 40 as shown in FIG. 4, thereby causing the piercer 26 to pierce through the sealed container 60, the finely divided material 64 is transferred from the container 60 to the air passageway of the piercer 26 from which it is dispensed upon inhalation by the user.
In use, the mouthpiece 24 of the inhalation devices of the present invention is placed inside the lips of the user to minimize impingement of the finely divided material on the mouth. A quick intake of breath causes air to flow through the air intake end 27 and into air passageway 22 of body member 20 to create a partial vacuum, thereby causing the finely divided material 64 to be dispersed from (i) the pierced and unsealed container 60 in the embodiment showing in FIGS. 1,3, and 9; and (ii) from the air passageway of the piercer 26 in the embodiment shown in FIG. 4.
Another preferred device in accordance with the present invention, shown in FIGS. 2 and 6, comprises a body member 20 having an air passageway 22 therethrough, and a holder 40. One end 24 of the body member 20 is adapted for insertion into the mouth of the user. The other end 27, the air intake end, of body member 20 is provided with a screen 28 to minimize inhalation of undesired materials, e.g., dust, which may be present in the air. A first piercer 26 for piercing the sealed container 60 while in the holder 40, extends into the interior of the holder 40 and has a passageway therethrough open to the body member 20 and the holder 40.
In the embodiment shown in FIGS. 2 and 6, the holder 40 is adapted to receive a disk 70 provided with multiple containers 60 as shown in FIG. 7. The holder 40 comprises a receptacle 42 fixed to the body member 20 and a cover 44 movably attached to receptacle 42 by hinge means 46. The disk 70 while in the holder 40 is rotably, centrally disposed on a pin (not shown) which is mounted therein.
The disk 70 is provided with a conventional locking means so that during rotation, the disk is locked in position each time a container of finely divided material is disposed adjacent piercers 26, 52, thereby locating each single dose container 60 for dispensation. Disks of a given diameter can contain different numbers of single doses depending upon the requirements of the particular drug in use. Thus, one inhalation device in accordance with the present invention can have many different drug applications.
A preferred multiple cavity disk 70 is about 0.75 to 1.25 inches in diameter, about 0.250 to 0.312 inches deep and is provided with individual sealed containers, similar to those shown in FIG. 5. The disk 70 is typically made of conventional molded plastics, such as, polypropylene, polyethylene, acetal, ABS and so forth. However, other conventional materials known to those skilled in the art may also be used. Although disk 70 can be rotated mechanically after use, for simplicity the preferred method is hard rotation. It will be apparent to those skilled in the art that the disk 70 could be replaced with multiple container strips, either rigid or in flexible rolls, e.g., as in cartridge belt for an automatic weapon, and so forth.
The cover 44 is provided with perforations 45 to provide an opening to the atmosphere through which air is drawn upon inhalation by the user when the pierced container 60 is in the device. The cover is also provided with a section 48 having a first leaf spring 50. Section 48 is movably mounted in the cover 44, flanges 49 providing stops to maintain section 48 in cover 44, when cover 44 is raised to insert a disk 70 of sealed containers 60.
A second piercer 52 mounted in cover section 48 extends into the interior of the holder 40 and has a passageway therethrough open at both ends to the holder 40. The second piercer 52 is positioned relative to the first piercer 26 so that they are capable of cooperating to pierce the sealed container 60 when the sealed container 60 is in receptacle 42 and rotated into dispersing position adjacent piercers 26, 50.
To operate the device shown in FIGS. 2 and 6, the movable cover section 48 is depressed by the user so that piercers 26 and 52 pierce the seals 61 (shown in FIG. 5) of the container 60 of finely divided material 64, thereby creating an air passage. The air passage is blocked only by the finely divided material 64, because the tab of pierced seal 66 is held against the side of holder 40 by piercer 26 (See FIG. 5). The movable cover section 48 is held in a depressed position until after inhalation by the user so that the piercers 52, 26 will remain in contact with the container 60 of finely divided material 64. The passage of air through the perforation in seal 62, needle 52, container 60, needle 26, and air passageway 22, virtually purges the finely divided material 64 from the container 60, carrying it along with the patients inspired breath into the lungs.
In preferred embodiments of the present invention, the air passageway 22 of the body member 20 comprises a venturi or a tube, wherein the first piercer 26 is disposed at or adjacent the smallest diameter of the venturi or the midpoint of the tube. A venturi is a particularly preferred configuration for the air passageway 22 of the body member as shown, e.g., in FIGS. 3A, 4, 6A and 8.
In one particularly preferred embodiment of the present invention, the body member 20 has a major diameter at each end ("B" in FIG. 6A) about 0.3 to 0.8 inches with, in the case of embodiments wherein the air passageway 22 composes a venturi, a minor diameter ("A" in FIG. 6A) at the venturi's point of restriction 23 of about 0.2 to 0.5 inches. These dimensions are based upon end 24 of body member 20 being adapted for insertion into the nose or mouth of the user, as well as providing a minor diameter adequately large to allow an uninhibited intake of breath. The inner diameter ("D" in FIG. 6A) of holder 40 is dimensioned to receive disk 70 and may be from about 0.5 to 1.5 inches when A and B have the dimensions set forth above. It is understood that the circumstances of use will dictate the dimensions without altering the intent of the device. For example, one might wish the unit to resemble a pocketable pen as shown in FIG. 8 to achieve an enhanced degree of portability.
The relative dimensions of the containers of finely divided material for use in the devices of the present invention and the piercer(s) of such devices are selected to provide accurate delivery of the finely divided material. The dimensions of the piercer 26 which opens to body member 20, as well as the end or ends of the container 60 pierced thereby, are selected to minimize entrapment of the finely divided material 64 adjacent piercer 26. Finely divided material below the orifice of the needle 26 is unlikely to evacuate, yet the needle 26 must project high enough to hold tab 66 (shown in FIG. 5) in a vertical position. If tab 66 is not held parallel to the sides of the container, it may be drawn down by the vacuum created upon inhalation to seal off piercer 26, thereby upsetting dosage accuracy.
In some preferred embodiments of the present invention, the diameter of the cylindrical container is stepped down at the end disposed adjacent piercer 26 while in the device, to minimize entrapment of the finely divided material. See, e.g., stepped down section 69 in FIG. 5. The step is preferably equal in length to the outside diameter of piercer 26 (i.e., about the size of tab 66 in the vertical position). The dimensions of piercer 52 are not as important since the tab created by piercer 52 is not positioned so that it will interfere with dispensing of the finely divided material. However, piercer 52 must be sufficiently large to permit unobstructed flow of air.
The inhalation devices of the present invention shown in the figures embody a piercer 26 which comprises a needle, preferably sharpened at the piercing end to about a 30° to 45° angle. The rim of the needle opposite the apex of the needle point is typically blunted to avoid cutting a piece of the seal 61 of container 60 free. As shown in FIG. 5, this leaves a tab 66 of the seal "hinged" to the container 60 thereby preventing ingestion.
In a preferred embodiment the needle 26 has an inner diameter of about 0.01 to 0.15 inches and an outer diameter of about 0.03 to 0.170 inches. Such inside diameters afford adequate flow of finely divided material while still retaining it in the container 40 until the moment of discharge. However, diameters outside the preferred ranges may be useful, depending in part upon the fluidity of the finely divided material. For example, a highly fluid finely divided material would call for a smaller diameter needle 26 than less fluid material in order to hold the powder inside the container 40 until evacuated by the inhalation of the user.
In preferred embodiments of the present invention, other than those similar to the embodiment shown in FIG. 4, the needle 26 extends into the container 60 for approximately one needle diameter length, plus the length of the sharpened angle, or sufficiently far to hold tab 66 in a position generally parallel to the side of the needle 26 and adjacent the inner wall of the container 40, thereby leaving a clear passage for air flow. This enables tab 66 to remain attached to the container 40 and to be bent to a position as shown in FIG. 5.
In embodiments wherein the needle 26 preferably has an inner diameter of about 0.01 to 0.15 inches and an outer diameter of about 0.03 to 0.170 inches, section 69 of the container has an inner diameter of about 0.180 to inches, and section 68 has a diameter of about 0.045 to about 0.190 inches. In a particularly preferred embodiments piercer 26 has an inner diameter of about 0.045 inches and an outer diameter of about 0.062 inches and the section 68 of container 60 has an inner diameter of about 0.070 inches and section 69 has an inner diameter of about 0.080 inches.
In embodiments of the present invention which include a second piercer 52, such as those shown in FIGS. 2, 6 and 8, the second piercer 52 is also preferably sharpened at the piercing end to about a 30° to 45° angle and the rim opposite the apex of the point is typically blunted. The inner diameter of piercer 52 is typically about 10 to 15% greater than the inner diameter of piercer 26.
In the embodiment shown in FIGS. 2 and 6, leaf springs 50 and 51 are preferably stainless steel and are about 0.005 to 0.015 inches, more preferably about 0.010 to 0.012 inches. Molded plastic springs can also be used but the extra thickness of such springs may be undesirable.
The configuration and dimensions of containers for use in the inhalation devices of the present invention are adapted to the particular device. For example, in embodiments wherein the piercer 26 is a needle, the container is preferably cylindrical. In some embodiments, the diameter of the container 60 is constant throughout, e.g., as shown in FIG. 4. In other embodiments, the container is provided with a first section 68 and a second section 69, narrower in diameter than section 68, as shown in, e.g., FIG. 5. In yet other embodiments of the present invention, e.g., as shown in FIG. 8, section 68 of container 60 tapers outwardly. This taper allows a greater volume of finely divided material to be loaded within a given depth. For proper evacuation of the container 60, the taper should not exceed an angle of about 10° to 15°.
In the embodiments shown in the figures, other than embodiments similar to the embodiment shown in FIG. 4, the inner diameter of section 68 of the container 60 is about 10 to 15% larger than the outer diameter of needle 26. In embodiments similar to that shown in FIG. 4, because the finely divided material is transferred to the needle as it pierces the container, the inner diameter of the container is only about 10 to 15% larger than the outer diameter of needle 26 to minimize any residue of finely divided material which may be left behind in the container.
The amount and fluidity of the finely divided material to be delivered will in large part determine the dimensions of the inhalation devices of the present invention. The devices of the present invention are capable of delivering amounts of finely divided material ranging from about 0.1 to 25 milligrams.
The dimensions of containers of the finely divided material for use in the present invention are also adapted for the particle size and amount of such material to be dispensed and, preferably, are large enough to provide an empty space 65 above the surface of the finely divided material. See, e.g., FIG. 5. This space 65 allows the finely divided material 64 to remain loose, avoiding agglomeration in storage and compaction from pressure as the needle 26 penetrates the container 60. In preferred embodiments, the container 60 is about half filled with finely divided material 64.
The particle size of the finely divided material to be delivered also influences the dimensions of the devices of the present invention. The desired particle size is determined, in part, by the mode of delivery, i.e., orally or nasally. Generally in oral administration, the intent is to get the greatest possible portion of the dose of finely divided material into the lungs and to avoid impingement on the lining of the buccal cavity. Whereas for nasal administration, it is desirable to have the major portion of the powder dose deposited on the nasal mucosa and the minimum amount carried to the lungs. A finer particle size and greater flow of air through the device of the present invention is used in oral delivery as compared with nasal delivery to accomplish the desired end. It is believed that the minimum air flow that would discharge the powder fully would also minimize the amount of powder carried to the lungs for nasal applications.
Containers for use in the present invention are sealed at one or both ends with a conventional piercable material, such as a plastic or metal film, using methods known to those skilled in the art. See, e.g., film 61 in FIG. 5. In such embodiments, the thickness of the film is about 0.002 to 0.004 inches. The desired characteristics for such sealing materials are high tensile strength to avoid tearing during perforation and resistance to the passage of moisture. In a preferred embodiment, a polyester film having heat activating adhesive on one side is used to seal the containers. Although polyester is preferred, other films known in the art, such as aluminum foil, may also be employed. In one preferred embodiment of the present invention wherein the container is removably sealed, the removable seal comprises a hermetic foil seal which is provided with an integral tab for ease of manual removal.
In the manufacture of embodiments of the present invention wherein multiple containers 60 are disposed in disk 70, the disk 70 is typically first sealed on one side with a piercable sealing material. The finely divided material 64 to be dispensed is then added to the multiple containers 60 disposed in disk 70 and the containers 60 are then hermetically sealed by sealing the other side of disk 70 either with a removable seal or with piercable sealing material.
The devices and containers of the present invention are made from conventional materials and by conventional techniques known to those of ordinary skill in the art. To ensure simple manufacture of such devices and containers, it is advantageous to use a readily processable plastic where suitable.
It will be apparent to the skilled artisan in light of the teachings of the present invention that configurations of body member 20, holder 40, piercer 26 and/or and piercers 26, 52 other than those shown may be utilized without departing from the spirit and scope of the invention.
For example, holder 40 may be connected to the body member 20 at various angles as illustrated in FIG. 9: FIG. 9A showing a 45° angle, FIGS. 9B and 9C a 90° angle, and FIG. 9D a 30° angle. In yet another embodiment shown in FIG. 8, body member 20, holder 40, and piercers 26 and 52 are arranged in parallel, i.e., at 0° angle. Furthermore, the embodiment shown in FIG. 8 is pocketable and less conspicuous in use, being somewhat pen-like in appearance.
In use, the cover 44 of the embodiment shown in FIG. 8 is removed, the sealed container 60 is inserted in the holder 40, and the bottom seal of container 60 is pierced. The cover 44 is replaced and pressed home to pierce the top seal. After removing the dust cap 54, the user places the mouthpiece 24 in the mouth and inhales. In preferred embodiments, the dimensions are as follows: overall length, about 3 to 6 inches; diameter, about 0.25 to 0.75 inches; length of body member 20, about 2 to 4 inches; length of cover 44, about 1.5 to 2.5 inches; length of piercer 26, about 1 to 1.75 inches; and length of piercer 52, about 0.375 to 0.75 inches. In one such preferred embodiment for oral inhalation the breath required for actuation of the device was only about 25 liters per minute. The dimensions of this device were as follows: overall length of about 3.375 inches; an inside diameter of about 0.32 inches at the widest section and 0.25 inches at the narrowest section of the venturi; body member 20 length of about 2.25 inches; holder 40 length of about 0.375 inches; piercer 26 length of about 1.1 inches; and piercer 52 length of about 0.5 inches.
In the adaptations of the embodiment shown in FIG. 8 for nasal inhalation, the internal diameter is reduced to restrict the air flow for delivery. For example, the narrowest section of the venturi can be reduced to about 0.187 inches in diameter to restrict the air flow. Furthermore, end 24 of the body member 20 is adapted to fit the human nose, and in some such embodiments, is bent upward at a 30° angle for comfort in use. Other than diameter, the basic dimensions are similar to those given above.
As is amply illustrated by the various embodiments in accordance with the present invention described herein, by following the teachings of the present invention one of ordinary skill in the art can vary the disclosed devices in structure by utilizing ordinary skill in the art to meet the demands of a particular finely divided material, particular user and so forth.
In order to illustrate the delivery advantages of the inhalation devices of the present invention, administration of cortisol tritiated (H3 -cortisol) using an inhalation device similar to that shown in FIGS. 1 and 3A was compared with conventional oral administration of H3 -cortisol by testing the urine of recipients of the H3 -cortisol for its presence.
Free, unmetabolized H3 -cortisol present in the urine reflects the amount of H3 -cortisol in circulation. By free cortisol is meant cortisol which has not been altered by the liver. It is known that when cortisol is ingested, a good portion is inactivated or metabolized in the liver.
FIG. 10 shows that more free H3 -cortisol was excreted in a 24 hour period in the urine when the H3 cortisol was administered via an inhalation device of the present invention as compared with ingestion. FIG. 11 shows that inhaled cortisol is more directly available for excretion in the urine at an earlier time than is ingested cortisol. These results give very powerful indirect evidence that the inhaled cortisol was not just swallowed but reached the alveolar epithelium and, thus, entered systemic circulation in a manner almost equivalent to delivery of H3 -cortisol intravenously. In contrast, the ingested cortisol was metabolized rapidly by the liver, because it was absorbed by the gut into the portal circulation.
A device similar to that shown in FIGS. 1 and 3A was tested to determine its delivery accuracy.
A container similar to that shown in FIGS. 3A and 5 was filled with about 3.24 mg of finely divided material and placed in the holder 40 of a device similar to that shown in FIGS. 1 and 3A. It was not necessary to provide the container with a removeable seal 62 because the finely divided material was dispensed immediately after being placed in the container. The method of discharge was by hand vacuum pump with a volume approximately equal to the human lung. A constant stroke was used in dispensing to minimize variation. Immediately after dispensing, the container was removed from the device and weighed again, and the residue of finely divided material determined. This process was repeated thirty-five times. The container was virtually purged with each delivery, and the residue remaining was very constant and very small. Thus, very accurate dose delivery was achieved by the use of a device of the present invention.
This invention will be further understood with reference to the following examples which are purely exemplary in nature and are not meant to limit the scope of the invention.
Administration of Tritiated Cortisol
A device similar to that shown in FIGS. 1 and 3A was used in this Example.
H3 -cortisol for inhalation and for oral ingestion was prepared as follows: 100 mg of cortisol was weighed in a clean crucible. 200 mμ of H3 -cortisol dissolved in ethanol was added to the powder, and thereafter, the ethanol was evaporated in a desiccator and the sample mixed well. The mixture of unlabelled and H3 -cortisol was ground with a stainless steel spoon shaped spatula. 5 mg of this mixture was weighed on glassene paper and then placed in a vial containing 0.5 ml of water and 5.0 ml of pico-fluor. Approximately 6,523,223 counts per minute/5 mg was prepared, giving a specific activity for H3 -cortisol of 1,279,063 counts/minute/mg.
10 mg of the H3 -cortisol was administered to one subject by use of an inhalation device of the present invention and to another subject orally.
The paper and tools used for weighing, as well the inhalation device were washed with ethanol and the amounts of H3 -cortisol found were then appropriately subtracted from the counts obtained from dose inhaled and ingested.
Excretion of free, unmetabolized cortisol as tritium was counted after extraction from the urine into dichloromethane, which was dried down and counted. The measurement of free H3 -cortisol was carried out via conventional radioimmunoassay procedures after preliminary purification by thin layer chromatography.
FIG. 10 demonstrates that of the total counts per minute excreted, for a 24 hour period the percent as free H3 -cortisol was approximately 25% for the inhaled dose and less than 5% for the ingested dose.
FIG. 11 shows counts per minute of free H3 -cortisol excreted over a 24 hour period for both oral ingestion and inhalation of the same dose. It can be seen that there was an early rise in counts per minute of free H3 -cortisol after inhalation which is not observed in the urine of an individual after oral ingestion of the labeled cortisol.
These results indicate that the inhaled H3 -cortisol reached the alveolar epithelium and the systematic circulation, whereas the ingested cortisol was metabolized rapidly because it was absorbed by the gut into the portal circulation.
It is understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof that will be suggested to persons skilled in the art are to be included in the spirit and purview of this application and the scope of the approved claims.
Claims (18)
1. A device for the oral or nasal inhalation of finely divided material from a sealed container of finely divided materials, the device comprising:
(i) a body member having a longitudinal axis and an air passageway along said longitudinal axis, a first end of the air passageway for insertion into the mouth of a user and a second end of the air passageway for intake of air responsive to inhalation of a user and wherein a venturi portion is located between the first and second ends;
(ii) a holder connected to the body member in the vicinity of the venturi for receiving at least one sealed container of finely divided material;
(iii) a first piercer for piercing a sealed container of finely divided material at the end thereof disposed adjacent the body member while a sealed container is in the holder, the first piercer extending from the body member and into the holder;
(iv) a second piercer for piercing the container while in the holder, the second piercer being capable of extending into the interior of the holder and having an air passageway therethrough open to the interior of the holder and to the atmosphere; and
(v) engaging means for causing the piercers, while a sealed container is in the holder, to pierce a sealed container of finely divided material;
whereby when the engaging means causes the first and second piercers to pierce a sealed container while in the holder to create an air passageway therethrough, air drawn through the first piercer, a pierced container, the second piercer, and the passageway of the body member cooperate to cause finely divided material disposed in a pierced container to be dispensed therefrom.
2. A device in accordance with claim 1, further comprising a locating means for positioning a sealed container to be pierced adjacent the first and second piercers while a sealed container is in a receptacle disposed in the holder.
3. A device in accordance with claim 1, wherein the first piercer is disposed at or adjacent the smallest diameter of the venturi or the midpoint of the tube.
4. A device in accordance with claim 1, wherein a sealed container to be pierced is cylindrical and a section extending above the first piercer while a sealed container is in the holder has an inner diameter of about 0.035 to 0.180 inches, the first piercer has an inner diameter of about 0.01 to 0.15 inches and an outer diameter of about 0.03 to 0.170 inches, and the second piercer has an inner diameter about 10 to 15% greater than the inner diameter of the first piercer.
5. A device in accordance with claim 1, wherein when a sealed container to be pierced is disposed in the holder and the engaging means causes the first and second piercers to pierce a sealed container, the first piercer extends into a sealed container for a distance sufficient to hold a pierced section of a sealed container against the inner surface of a sealed container.
6. A device in accordance with claim 1, wherein the holder is adapted to receive a disk comprising multiple sealed containers of finely divided material.
7. A device in accordance with claim 1, wherein the air passageway of the venturi has a minor diameter of about 0.2 to 0.5 inches and a major diameter of about 0.3 to 0.8 inches.
8. A device for the oral or nasal inhalation of finely divided material from a sealed container of finely divided materials, the device comprising:
(i) a body member having a longitudinal axis and an air passageway along said longitudinal axis, a first end of the air passageway for insertion into the mouth of a user and a second end of the air passageway for intake of air responsive to inhalation of a user and wherein a venturi portion is located between the first and second ends;
(ii) a holder connected to the body member in the vicinity of the venturi portion for receiving at least one container of finely divided material; and
(iii) a single piercer for piercing of a sealed container of finely divided materials responsive to the insertion of a sealed container into the holder, the piercer extending from the body member and into the holder and having a passageway having an inner opening only slightly smaller than the inner diameter of a sealed container;
whereby when a removably sealed container is placed in the holder thereby causing the piercer to pierce a sealed container and a sealed container is unsealed, air drawn through an unsealed and pierced container, the piercer, and the body member cooperate to cause finely divided material disposed in an unsealed container to be dispensed therefrom.
9. A device for the oral or nasal inhalation of finely divided material from a sealed container which comprises:
(i) a body member having a longitudinal axis and an air passageway along said longitudinal axis, a first end of the air passageway for insertion into the mouth of a user and a second end of the air passageway for intake of air responsive to inhalation of a user and wherein a venturi portion is located between the first and second ends;
(ii) a holder connected to the body member in the vicinity of the venturi for receiving at least one sealed container of finely divided material; and
(iii) at least one piercer for piercing through a sealed container while a sealed container is in the holder, the piercer having a passageway therethrough open to the body member and to the holder and extending from the body member through the holder for a distance greater than the dimension of a sealed container to be pierced;
whereby when a sealed container is placed in the holder thereby causing the piercer to pierce through a sealed container and the transfer of the finely divided material from a container to the passageway of the piercer, air drawn through the piercer and the air passageway of the body member cooperate to cause the finely divided material disposed in the piercer to be dispensed therefrom.
10. The device of claim 9, wherein the piercer is approximately cylindrical and a sealed container to be pierced has an inner diameter greater than the outer diameter of the piercer by about 10 to 20%.
11. A device in accordance with claims 8, 9, or 1, wherein the piercer comprises a needle.
12. A device in accordance with claim 11, wherein the needle means is sharpened at the piercing end to about a 30° to 45° angle and the rim of the needle opposite the apex is blunted.
13. A device in accordance with claims 8, 9, or 1, wherein a sealed container to be pierced is a cylindrically shaped cartridge sealed at both ends and partially filled with finely divided material.
14. A device in accordance with claims 8 or 1, wherein both a sealed container to be pierced and the piercer are cylindrical and the end of a sealed container which is to be disposed adjacent the body member while in the holder, has a diameter about 0.005 to 0.015 inches greater than the diameter of the piercer extending from the body member.
15. A device in accordance with claim 14, wherein the diameter of the end of a sealed container to be pierced which is to be disposed adjacent the body member while in the holder, increases about 10 to 20% at a distance from said end about equal to the diameter of the piercer extending from the body member.
16. A device in accordance with claims 8, 9, or 1, wherein a sealed container to be pierced is provided with up to about 25 mg of finely divided material.
17. A device in accordance with claims 8, 9, or 1, wherein a sealed container to be pierced is provided with about 0.5 to 5 mg of finely divided material.
18. A device in accordance with claims 8, 9, or 1 wherein the holder has a longitudinal axis from substantially perpendicular to at about a 45° angle to the longitudinal axis of said body member.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/250,060 US5529059A (en) | 1991-08-01 | 1994-05-27 | Inhalation devices |
US08/672,020 US5715810A (en) | 1991-07-25 | 1996-06-24 | Inhalation devices |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/738,924 US5337740A (en) | 1991-08-01 | 1991-08-01 | Inhalation devices |
US08/250,060 US5529059A (en) | 1991-08-01 | 1994-05-27 | Inhalation devices |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/735,924 Continuation US5152722A (en) | 1990-07-25 | 1991-07-25 | Transmission belt assembly |
US07/738,924 Continuation US5337740A (en) | 1991-07-25 | 1991-08-01 | Inhalation devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/672,020 Continuation US5715810A (en) | 1991-07-25 | 1996-06-24 | Inhalation devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US5529059A true US5529059A (en) | 1996-06-25 |
Family
ID=24970056
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/738,924 Expired - Lifetime US5337740A (en) | 1991-07-25 | 1991-08-01 | Inhalation devices |
US08/250,060 Expired - Fee Related US5529059A (en) | 1991-07-25 | 1994-05-27 | Inhalation devices |
US08/672,020 Expired - Fee Related US5715810A (en) | 1991-07-25 | 1996-06-24 | Inhalation devices |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US07/738,924 Expired - Lifetime US5337740A (en) | 1991-07-25 | 1991-08-01 | Inhalation devices |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/672,020 Expired - Fee Related US5715810A (en) | 1991-07-25 | 1996-06-24 | Inhalation devices |
Country Status (15)
Country | Link |
---|---|
US (3) | US5337740A (en) |
EP (1) | EP0525720B1 (en) |
JP (1) | JPH07108316B2 (en) |
AT (1) | ATE146363T1 (en) |
AU (1) | AU665765B2 (en) |
CA (1) | CA2075113A1 (en) |
DE (1) | DE69215994T2 (en) |
DK (1) | DK0525720T3 (en) |
ES (1) | ES2097839T3 (en) |
FI (1) | FI923404A (en) |
GR (1) | GR3022762T3 (en) |
MX (1) | MX9204499A (en) |
NO (1) | NO305852B1 (en) |
NZ (1) | NZ243649A (en) |
ZA (1) | ZA925718B (en) |
Cited By (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5715810A (en) * | 1991-07-25 | 1998-02-10 | Sepracor Inc. | Inhalation devices |
US5794613A (en) * | 1997-01-09 | 1998-08-18 | Sepracor, Inc. | Multiple-dose dispenser for dry powder inhalers |
US6234459B1 (en) | 1998-03-18 | 2001-05-22 | Lytesyde, Llc | Medication processing system and method |
US6273085B1 (en) | 1997-03-20 | 2001-08-14 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6341605B1 (en) * | 1998-02-05 | 2002-01-29 | Unisia Jecs Corporation | Inhalant medicator |
GB2372215A (en) * | 2000-06-23 | 2002-08-21 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US20020134382A1 (en) * | 2000-05-10 | 2002-09-26 | Snow John M. | Medicament container with same side airflow inlet and outlet and method of use |
US20020168322A1 (en) * | 1998-10-09 | 2002-11-14 | Andrew Clark | Flow resistance modulated aerosolized active agent delivery |
US6484715B1 (en) * | 1998-07-14 | 2002-11-26 | Ing. Erich Pfeiffer Gmbh | Media dispenser |
US20030015191A1 (en) * | 2001-04-26 | 2003-01-23 | New England Pharmaceuticals, Inc. | Metered dose delivery device for liquid and powder agents |
US6550477B1 (en) * | 1995-08-02 | 2003-04-22 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
US6655379B2 (en) | 1998-03-16 | 2003-12-02 | Nektar Therapeutics | Aerosolized active agent delivery |
US20040000309A1 (en) * | 2002-06-18 | 2004-01-01 | William Alston | Flow regulator for aerosol drug delivery and methods |
US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US20040237961A1 (en) * | 1995-06-08 | 2004-12-02 | Snow John Medlin | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US20070051362A1 (en) * | 2004-04-23 | 2007-03-08 | Sullivan Timothy R | Multiple unit dose drug delivery system |
US20070169773A1 (en) * | 2006-01-23 | 2007-07-26 | Lytesyde, Llc | Medical liquid processor apparatus and method |
US20070169760A1 (en) * | 2006-01-23 | 2007-07-26 | Rock Kelly P | Fuel processor apparatus and method |
US20080177246A1 (en) * | 2007-01-09 | 2008-07-24 | First City Tower | Intranasal Cartridge Devices |
US20080314384A1 (en) * | 2004-12-09 | 2008-12-25 | David Stuart Harris | Dry Powder Inhalers |
US20090038582A1 (en) * | 2007-08-07 | 2009-02-12 | Lytesyde, Llc | Fuel Processor Apparatus and Method |
US20090071108A1 (en) * | 2007-09-14 | 2009-03-19 | Mystic Pharmaceuticals, Inc. | Deep draw container forming method |
US20090137950A1 (en) * | 2007-11-23 | 2009-05-28 | Pari Pharma Gmbh | Disposable ampoule for an aerosol generating device |
US20090293868A1 (en) * | 2005-08-16 | 2009-12-03 | Pari Pharma Gmbh | Inhalation Therapy Device Comprising an Ampoule for Storing a Medicament To Be Nebulized |
US7669597B2 (en) | 2007-05-16 | 2010-03-02 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
US20100078022A1 (en) * | 2008-09-26 | 2010-04-01 | Rachel Striebig | Inhalers with airway disks having discrete airway channels and related disks and methods |
USD635246S1 (en) | 2010-03-26 | 2011-03-29 | Oriel Therapeutics, Inc. | Dose disk for dry powder inhalers |
USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
US20110162648A1 (en) * | 2008-09-26 | 2011-07-07 | Ruckdeschel Thomas W | Inhaler mechanisms with radially biased piercers and related methods |
US20110174306A1 (en) * | 2008-09-30 | 2011-07-21 | David Harris | Dry Powder Inhalers with Multi-Facet Surface Deagglomeration Chambers and Related Devices and Methods |
US20110186047A1 (en) * | 2008-10-01 | 2011-08-04 | Scott Alexander Lewis | Dry Powder Inhalers with Rotating Piercing Mechanisms and Related Devices and Methods |
US8381721B2 (en) | 2008-09-26 | 2013-02-26 | Oriel Therapeutics, Inc. | Dry powder inhalers with dual piercing members and related devices and methods |
US8683995B2 (en) | 2007-05-16 | 2014-04-01 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US20140216457A1 (en) * | 2005-07-20 | 2014-08-07 | Manta Devices, Llc | Inhalation device |
US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US20160356427A1 (en) * | 2006-11-27 | 2016-12-08 | Frank Levy | Disposable cartridge for holding compressed medical gas |
US9861578B1 (en) * | 2017-05-11 | 2018-01-09 | Yuri Issac Busiashvili | Sublingual dosimetric drip caged ball valve device |
US9919115B2 (en) | 2007-07-06 | 2018-03-20 | Manta Devices, Llc | Dose delivery device for inhalation with first and second portions to open a dose chamber |
US20180087718A1 (en) * | 2006-11-27 | 2018-03-29 | Frank Levy | Disposable single-use cartridge for holding compressed medical gas |
US11147936B2 (en) | 2014-05-02 | 2021-10-19 | Manta Devices, Llc | Dose delivery device with cover connected to dose chamber seal |
US11224704B2 (en) | 2007-07-06 | 2022-01-18 | Manta Devices, Llc | Dose delivery device for inhalation |
Families Citing this family (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE35552E (en) * | 1991-04-15 | 1997-07-08 | Leiras Oy | Device intended for measuring a dose of powered medicament for inhalation |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
CA2112674C (en) * | 1991-07-02 | 2005-10-04 | John S. Patton | Method and device for delivering aerosolized medicaments |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
EP0659095B1 (en) * | 1992-09-11 | 1998-04-29 | Glaxo Group Limited | Inhalation device |
US5533502A (en) * | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
ES2148477T3 (en) * | 1993-12-18 | 2000-10-16 | Merck Patent Gmbh | POWDER INHALER. |
US5415162A (en) * | 1994-01-18 | 1995-05-16 | Glaxo Inc. | Multi-dose dry powder inhalation device |
US5483954A (en) * | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
JP3388896B2 (en) * | 1994-08-08 | 2003-03-24 | 株式会社日立ユニシアオートモティブ | Inhalation type dispenser |
AU697676B2 (en) * | 1994-09-21 | 1998-10-15 | Nektar Therapeutics | Apparatus and methods for dispersing dry powder medicaments |
IT1277832B1 (en) * | 1995-03-02 | 1997-11-12 | Giuseppina Magni | PACKAGING FOR NEBULIZABLE SUBSTANCES |
DE19523516C1 (en) * | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhaler for administering medication from blister packs |
FR2738152B1 (en) * | 1995-09-04 | 1998-01-23 | Tebro | POWDER PRODUCT PREDOSING DEVICE FOR A PRODUCT DISPENSER |
US5669378A (en) * | 1995-12-21 | 1997-09-23 | Pera; Ivo | Inhaling device |
CN1173751C (en) | 1996-04-25 | 2004-11-03 | 阿斯特拉泽尼卡公司 | Inhaler |
DE19637101A1 (en) * | 1996-09-12 | 1998-03-19 | Pfeiffer Erich Gmbh & Co Kg | Discharge device for media |
GB9626233D0 (en) * | 1996-12-18 | 1997-02-05 | Chawla Brinda P S | Medicament packaging and deliveery device |
US6009869A (en) * | 1997-12-29 | 2000-01-04 | Allegiance Corporation | Supersonic nozzle nebulizer |
US7963955B2 (en) * | 1998-02-27 | 2011-06-21 | Boehringer Ingelheim International Gmbh | Container for a medicinal liquid |
US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
US6234169B1 (en) | 1998-08-14 | 2001-05-22 | Arthur Slutsky | Inhaler |
GB9902493D0 (en) | 1999-02-05 | 1999-03-24 | Glaxo Group Ltd | Inhalation device |
DE19940713A1 (en) * | 1999-02-23 | 2001-03-01 | Boehringer Ingelheim Int | Diffusion resistant cartridge for storing and dosing liquids, especially for producing drug-containing inhalable aerosols, has three-shell structure with collapsible bag, container and rigid housing |
US20050279949A1 (en) * | 1999-05-17 | 2005-12-22 | Applera Corporation | Temperature control for light-emitting diode stabilization |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
GB2356457A (en) * | 1999-09-23 | 2001-05-23 | Meldet Ltd | Device for measuring airflow in a nostril |
EP1220698B1 (en) * | 1999-10-12 | 2004-07-21 | SHL Medical AB | Inhaler |
DE19956260A1 (en) * | 1999-11-23 | 2001-05-31 | Inamed Gmbh | Separator unit e.g. for dry powder medicines in inhalers, comprises a pipe with a filter unit arranged perpendicularly to its axis, and a mantle that surrounds the filter unit area |
US6810872B1 (en) | 1999-12-10 | 2004-11-02 | Unisia Jecs Corporation | Inhalant medicator |
US20010029947A1 (en) | 1999-12-17 | 2001-10-18 | Steve Paboojian | Receptacles to facilitate the extraction of powders |
AU2001234005B2 (en) * | 2000-02-28 | 2006-01-19 | Pharmakodex Limited | Improvements in or relating to the delivery of oral drugs |
GB2364919A (en) | 2000-07-21 | 2002-02-13 | Cambridge Consultants | Inhalers |
GB0100756D0 (en) * | 2001-01-11 | 2001-02-21 | Powderject Res Ltd | Needleless syringe |
ZA200306564B (en) * | 2001-02-26 | 2004-10-15 | Optinose As | Nasal devices. |
DE60101451T2 (en) * | 2001-03-05 | 2004-10-21 | Pera Ivo E | Inhaler for distributing powdered medication in a capsule through the respiratory tract |
US6743259B2 (en) * | 2001-08-03 | 2004-06-01 | Core Medical, Inc. | Lung assist apparatus and methods for use |
GB0130055D0 (en) | 2001-12-14 | 2002-02-06 | Technology Innovation Ltd | Medicament packaging |
GB0205572D0 (en) | 2002-03-09 | 2002-04-24 | Chawla Brinda P S | Medicament delivery and packaging |
JP4681231B2 (en) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | Inhaler |
GB2403154B (en) * | 2002-04-04 | 2007-01-24 | Optinose As | Nasal devices |
EP1587482A4 (en) * | 2003-01-31 | 2010-08-25 | Technion Res & Dev Foundation | Anti-inflammatory compositions and uses thereof |
PE20040950A1 (en) | 2003-02-14 | 2005-01-01 | Theravance Inc | BIPHENYL DERIVATIVES AS AGONISTS OF ß2-ADRENERGIC RECEPTORS AND AS ANTAGONISTS OF MUSCARINAL RECEPTORS |
EP1603810B1 (en) | 2003-03-15 | 2010-08-11 | Brin Tech International Limited | Medicament package |
CA2519228C (en) * | 2003-03-20 | 2014-10-14 | Galephar M/F | Improved dry powder inhaler system |
TW200510298A (en) | 2003-06-13 | 2005-03-16 | Theravance Inc | Substituted pyrrolidine and related compounds |
TWI341836B (en) | 2004-03-11 | 2011-05-11 | Theravance Inc | Biphenyl compounds useful as muscarinic receptor antagonists |
BRPI0514263B8 (en) | 2004-08-20 | 2021-05-25 | Mannkind Corp | method for the synthesis of n-protected bis-3,6-[4-aminobutyl]-2,5-diketopiperazine n-protected |
KR101306384B1 (en) | 2004-08-23 | 2013-09-09 | 맨카인드 코포레이션 | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
US20060120972A1 (en) * | 2004-11-09 | 2006-06-08 | Peter Engels | 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension |
GB0427858D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
GB0427853D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
GB0503738D0 (en) * | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
DE102005016100B3 (en) * | 2005-04-08 | 2006-10-26 | Altana Pharma Ag | Device for metering and dry fogging |
GB0507711D0 (en) | 2005-04-15 | 2005-05-25 | Vectura Group Plc | Improved blister piercing |
WO2007007110A1 (en) * | 2005-07-13 | 2007-01-18 | Cipla Limited | Inhaler device |
EP1928423B1 (en) | 2005-09-14 | 2015-12-09 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
AR058290A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | MEDICINAL DISPENSER |
AR058289A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | COLLECTOR TO BE USED IN MEDICINAL DISPENSER |
WO2007098500A2 (en) | 2006-02-22 | 2007-08-30 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
EP1844806A1 (en) * | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH | Device for delivery of medicaments, magazine for medicaments, and method for withdrawing medicaments from a medicament chamber |
GB0708758D0 (en) | 2007-05-04 | 2007-06-13 | Powderject Res Ltd | Particle cassettes and process thereof |
EP2011538B1 (en) * | 2007-07-06 | 2016-02-17 | Vectura Delivery Devices Limited | Inhaler |
WO2009046215A2 (en) * | 2007-10-02 | 2009-04-09 | Lab International Srl | Safety and abuse deterrent improved device |
US20090084379A1 (en) * | 2007-10-02 | 2009-04-02 | Baxter International Inc. | Dry powder inhaler |
EP2268274B1 (en) | 2008-03-20 | 2012-05-16 | Virun, Inc. | Vitamin e derivatives and their uses |
CN107080734B (en) | 2008-03-20 | 2020-10-30 | 维尔恩公司 | Emulsions comprising PEG derivatives of tocopherols |
MX371521B (en) * | 2008-03-27 | 2020-01-31 | Mannkind Corp | A dry powder inhalation system. |
AU2009244462B2 (en) * | 2008-05-06 | 2013-04-11 | Cook Medical Technologies Llc | Apparatus and methods for delivering therapeutic agents |
CA2982550C (en) | 2008-06-13 | 2020-08-25 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
CN102065942B (en) | 2008-06-20 | 2013-12-11 | 曼金德公司 | An interactive apparatus and method for real-time profiling of inhalation efforts |
WO2010008475A2 (en) * | 2008-06-23 | 2010-01-21 | Virun, Inc. | Compositions containing nono-polar compounds |
JP5339794B2 (en) * | 2008-07-04 | 2013-11-13 | キヤノン株式会社 | Inhaler |
TWI494123B (en) | 2008-08-11 | 2015-08-01 | Mannkind Corp | Use of ultrarapid acting insulin |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
WO2010091198A1 (en) | 2009-02-06 | 2010-08-12 | University Of Southern California | Therapeutic compositions comprising monoterpenes |
PL2405963T3 (en) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Apparatus, system and method for measuring resistance of an inhaler |
ES2943333T3 (en) | 2009-06-12 | 2023-06-12 | Mannkind Corp | Diketopiperazine microparticles with defined surface areas |
MX2012000682A (en) | 2009-07-15 | 2012-02-28 | Theravance Inc | Crystalline freebase forms of a biphenyl compound. |
EP2477642A4 (en) * | 2009-09-17 | 2013-03-13 | Mutual Pharmaceutical Co | Method of treating asthma with antiviral agents |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
CN104744215B (en) | 2010-03-03 | 2019-03-15 | 尼昂克技术公司 | Pharmaceutical composition comprising monoterpene |
CN103037708B (en) | 2010-03-23 | 2015-05-20 | 维尔恩公司 | Nanoemulsion including sucrose fatty acid ester |
US20110303218A1 (en) * | 2010-06-09 | 2011-12-15 | Yadidi Kambiz | Nasal nebulizer |
US8741373B2 (en) | 2010-06-21 | 2014-06-03 | Virun, Inc. | Compositions containing non-polar compounds |
AU2011271097B2 (en) | 2010-06-21 | 2014-11-27 | Mannkind Corporation | Dry powder drug delivery system and methods |
US9499461B2 (en) | 2010-08-27 | 2016-11-22 | Neonc Technologies, Inc. | Pharmaceutical compositions comprising POH derivatives |
US20160038600A1 (en) | 2012-08-03 | 2016-02-11 | Neonc Technologies Inc. | Pharmaceutical compositions comprising poh derivatives |
US9211269B2 (en) | 2010-12-17 | 2015-12-15 | Neonc Technologies Inc. | Methods and devices for using isoperillyl alcohol |
CN103826988B (en) | 2011-04-01 | 2016-03-09 | 曼金德公司 | For the blister package of pharmaceutical kit |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
JP6018640B2 (en) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | Analgesic composition effective for alleviating pain, and dry powder and dry powder drug delivery system comprising the composition |
EP2811847B1 (en) | 2012-02-10 | 2017-12-13 | Virun, Inc. | Beverage compositions containing non-polar compounds |
US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
HUE038638T2 (en) | 2012-09-26 | 2018-12-28 | Boehringer Ingelheim Int | Inhalator |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
GB201301192D0 (en) | 2013-01-23 | 2013-03-06 | Vectura Delivery Devices Ltd | A blister piercing element for a dry powder inhaler |
US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
KR102391750B1 (en) | 2013-03-15 | 2022-04-28 | 맨카인드 코포레이션 | Microcrystalline diketopiperazine compositions and methods |
CA2909954C (en) | 2013-04-28 | 2021-03-23 | Impel Neuropharma, Inc. | Medical unit dose container |
US10835691B2 (en) * | 2013-05-17 | 2020-11-17 | Koninklijke Philips N.V. | Substance delivery module |
CN105451716A (en) | 2013-07-18 | 2016-03-30 | 曼金德公司 | Heat-stable dry powder pharmaceutical compositions and methods |
US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
USD773033S1 (en) * | 2014-02-25 | 2016-11-29 | Pari Pharma Gmbh, Inc. | Inhalation device |
USD773034S1 (en) * | 2014-02-25 | 2016-11-29 | PHARI Pharma GmbH, Inc. | Inhalation device head |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
CN103877655B (en) * | 2014-04-08 | 2015-12-30 | 隋宁昕 | The fixed oxygen inhaling nose stuffer of self-priming |
WO2015180167A1 (en) * | 2014-05-30 | 2015-12-03 | 深圳麦克韦尔股份有限公司 | Electronic cigarette and atomizer thereof |
US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2016078763A1 (en) | 2014-11-20 | 2016-05-26 | Boehringer Ingehlheim Vetmedica Gmbh | Container for an inhaler |
DE102015000351B3 (en) * | 2015-01-19 | 2016-05-04 | Klaus Dieter Beller | Powder inhaler, its units powder container and air duct housing, and use of the Pulverinhaltor |
WO2016130800A2 (en) | 2015-02-12 | 2016-08-18 | Neonc Technologies Inc. | Pharmaceutical compositions comprising perillyl alcohol derivatives |
US10765821B2 (en) | 2015-03-19 | 2020-09-08 | Altria Client Services Llc | Vaporizer for vaporizing a constituent of a plant material |
US10179215B2 (en) | 2015-03-19 | 2019-01-15 | Altria Client Services Llc | Vaporizer for vaporizing a constituent of a plant material |
AU2016261113A1 (en) * | 2015-05-12 | 2018-01-04 | Cipla Europe Nv | Inhaler device |
WO2018102412A1 (en) | 2016-11-30 | 2018-06-07 | Neonc Technologies, Inc. | A perillyl alcohol-3 bromopyruvate conjugate and methods of treating cancer |
EP3599899A1 (en) | 2017-03-23 | 2020-02-05 | Virun, Inc. | Stable dry powders and emulsions containing probiotics and mucoadhesive protein |
EP3612260B1 (en) * | 2017-04-20 | 2024-03-27 | Syqe Medical Ltd. | Replaceable flow tract for an inhaler |
CA3225993A1 (en) | 2018-02-08 | 2019-08-15 | University Of Southern California | The use of monoterpene, sesquiterpene, or their derivatives to permeabilize the blood brain barrier |
WO2020182322A1 (en) | 2019-03-14 | 2020-09-17 | Om Pharma Sa | Method of treating and/or preventing asthma, asthma exacerbations, allergic asthma and/or associated conditions with microbiota related to respiratory disorders |
USD916361S1 (en) | 2019-06-25 | 2021-04-13 | Altria Client Services Llc | Aerosol-generating capsule |
US11458262B2 (en) | 2019-06-25 | 2022-10-04 | Altria Client Services Llc | Capsules, heat-not-burn (HNB) aerosol-generating devices, and methods of generating an aerosol |
US11789476B2 (en) | 2021-01-18 | 2023-10-17 | Altria Client Services Llc | Heat-not-burn (HNB) aerosol-generating devices including intra-draw heater control, and methods of controlling a heater |
US11910826B2 (en) | 2021-01-18 | 2024-02-27 | Altria Client Services Llc | Heat-not-burn (HNB) aerosol-generating devices and capsules |
WO2023205389A1 (en) | 2022-04-22 | 2023-10-26 | Quench Medical Inc. | Dry powder inhalation delivery of pharmaceuticals |
WO2023232976A1 (en) | 2022-06-03 | 2023-12-07 | Ags Therapeutics Sas | Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses |
WO2024033662A1 (en) * | 2022-08-12 | 2024-02-15 | Cambridge Healthcare Innovations Limited | Negative pressure amplification apparatus and inhaler |
Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB467172A (en) * | 1934-12-08 | 1937-06-07 | Algemeene Kunstzijde Unie Nv | Method and apparatus for the winding of spools in the spinning of artificial silks |
US2519555A (en) * | 1945-08-31 | 1950-08-22 | Abbott Lab | Sterile medicament insufflator cartridge and insufflator |
US2944547A (en) * | 1955-12-09 | 1960-07-12 | Z And W Machine Products Inc | Portable anesthesia machine, oxygen inhalator and resuscitator |
US3425414A (en) * | 1965-05-28 | 1969-02-04 | William J La Roche | Inhalant dispenser |
US3507277A (en) * | 1966-09-17 | 1970-04-21 | Fisons Pharmaceuticals Ltd | Inhalation device |
US3635214A (en) * | 1970-07-29 | 1972-01-18 | William A Rand | Visual pulmonary meter |
US3659598A (en) * | 1969-06-17 | 1972-05-02 | Gen Medical Corp | Respirator with fluid amplifiers with fluid timer |
US3888252A (en) * | 1974-01-23 | 1975-06-10 | Anthony J Side | Powder inhaler |
US3888253A (en) * | 1972-08-04 | 1975-06-10 | Beecham Group Ltd | Device for administration of medicines |
US3938516A (en) * | 1975-01-13 | 1976-02-17 | Syntex Puerto Rico, Inc. | Inhalation device |
US3948264A (en) * | 1975-05-21 | 1976-04-06 | Mead Johnson & Company | Inhalation device |
US4014336A (en) * | 1975-01-13 | 1977-03-29 | Syntex Puerto Rico, Inc. | Inhalation device |
FR2352556A1 (en) * | 1976-05-26 | 1977-12-23 | Pasteur Institut | Nasal and oral powder inhaler for medicines etc. - uses cyclone chamber to entrain powder into air stream |
US4064878A (en) * | 1975-06-13 | 1977-12-27 | Syntex Puerto Rico, Inc. | Inhalation device |
NZ179725A (en) * | 1975-01-13 | 1978-06-20 | Syntex Puerto Rico Inc | Medicament dispensing inhalation device |
FR2454813A1 (en) * | 1979-04-27 | 1980-11-21 | Sigma Tau Ind Farmaceuti | DEVICE FOR RAPID INHALATION OF PHARMACEUTICAL POWDER PRODUCTS BY MAN |
US4240418A (en) * | 1974-08-22 | 1980-12-23 | Schering Aktiengesellschaft | Apparatus for the inhalation of medicinal agents |
US4291688A (en) * | 1979-01-11 | 1981-09-29 | Schering Corp. | Inhalation device |
GB2129691A (en) * | 1982-10-08 | 1984-05-23 | Glaxo Group Ltd | Devices for administering medicaments to patients |
GB2142246A (en) * | 1983-05-24 | 1985-01-16 | Glaxo Group Ltd | Medical administration devices |
GB2169265A (en) * | 1982-10-08 | 1986-07-09 | Glaxo Group Ltd | Pack for medicament |
GB2175865A (en) * | 1985-05-29 | 1986-12-10 | Stanwell Smith Colin Howard | Propellers for boats |
US4778054A (en) * | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
US4811731A (en) * | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
CA2020425A1 (en) * | 1989-07-04 | 1991-01-05 | Michel Brunet | Device for projecting a dose of divisible substance |
US4995385A (en) * | 1989-02-23 | 1991-02-26 | Phidea S.P.A. | Inhaler with regular complete emptying of the capsule |
US5337740A (en) * | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
-
1991
- 1991-08-01 US US07/738,924 patent/US5337740A/en not_active Expired - Lifetime
-
1992
- 1992-07-20 AU AU20384/92A patent/AU665765B2/en not_active Ceased
- 1992-07-21 NZ NZ243649A patent/NZ243649A/en unknown
- 1992-07-28 DK DK92112857.5T patent/DK0525720T3/en active
- 1992-07-28 EP EP92112857A patent/EP0525720B1/en not_active Expired - Lifetime
- 1992-07-28 DE DE69215994T patent/DE69215994T2/en not_active Expired - Fee Related
- 1992-07-28 FI FI923404A patent/FI923404A/en not_active Application Discontinuation
- 1992-07-28 AT AT92112857T patent/ATE146363T1/en not_active IP Right Cessation
- 1992-07-28 ES ES92112857T patent/ES2097839T3/en not_active Expired - Lifetime
- 1992-07-30 NO NO923016A patent/NO305852B1/en not_active IP Right Cessation
- 1992-07-30 ZA ZA925718A patent/ZA925718B/en unknown
- 1992-07-31 CA CA002075113A patent/CA2075113A1/en not_active Abandoned
- 1992-07-31 JP JP4225223A patent/JPH07108316B2/en not_active Expired - Lifetime
- 1992-07-31 MX MX9204499A patent/MX9204499A/en not_active IP Right Cessation
-
1994
- 1994-05-27 US US08/250,060 patent/US5529059A/en not_active Expired - Fee Related
-
1996
- 1996-06-24 US US08/672,020 patent/US5715810A/en not_active Expired - Fee Related
-
1997
- 1997-03-07 GR GR970400446T patent/GR3022762T3/en unknown
Patent Citations (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB467172A (en) * | 1934-12-08 | 1937-06-07 | Algemeene Kunstzijde Unie Nv | Method and apparatus for the winding of spools in the spinning of artificial silks |
US2519555A (en) * | 1945-08-31 | 1950-08-22 | Abbott Lab | Sterile medicament insufflator cartridge and insufflator |
US2944547A (en) * | 1955-12-09 | 1960-07-12 | Z And W Machine Products Inc | Portable anesthesia machine, oxygen inhalator and resuscitator |
US3425414A (en) * | 1965-05-28 | 1969-02-04 | William J La Roche | Inhalant dispenser |
US3507277A (en) * | 1966-09-17 | 1970-04-21 | Fisons Pharmaceuticals Ltd | Inhalation device |
US3659598A (en) * | 1969-06-17 | 1972-05-02 | Gen Medical Corp | Respirator with fluid amplifiers with fluid timer |
US3635214A (en) * | 1970-07-29 | 1972-01-18 | William A Rand | Visual pulmonary meter |
US3888253A (en) * | 1972-08-04 | 1975-06-10 | Beecham Group Ltd | Device for administration of medicines |
US3888252A (en) * | 1974-01-23 | 1975-06-10 | Anthony J Side | Powder inhaler |
US4240418A (en) * | 1974-08-22 | 1980-12-23 | Schering Aktiengesellschaft | Apparatus for the inhalation of medicinal agents |
NZ179724A (en) * | 1975-01-13 | 1978-07-28 | Syntex Puerto Rico Inc | Medicament dispensing in halation device |
NZ179725A (en) * | 1975-01-13 | 1978-06-20 | Syntex Puerto Rico Inc | Medicament dispensing inhalation device |
US4098273A (en) * | 1975-01-13 | 1978-07-04 | Syntex Puerto Rico, Inc. | Inhalation device |
US4014336A (en) * | 1975-01-13 | 1977-03-29 | Syntex Puerto Rico, Inc. | Inhalation device |
US3938516A (en) * | 1975-01-13 | 1976-02-17 | Syntex Puerto Rico, Inc. | Inhalation device |
US3948264A (en) * | 1975-05-21 | 1976-04-06 | Mead Johnson & Company | Inhalation device |
US4064878A (en) * | 1975-06-13 | 1977-12-27 | Syntex Puerto Rico, Inc. | Inhalation device |
US4105027A (en) * | 1975-06-13 | 1978-08-08 | Syntex Puerto Rico, Inc. | Inhalation device |
FR2352556A1 (en) * | 1976-05-26 | 1977-12-23 | Pasteur Institut | Nasal and oral powder inhaler for medicines etc. - uses cyclone chamber to entrain powder into air stream |
US4291688A (en) * | 1979-01-11 | 1981-09-29 | Schering Corp. | Inhalation device |
US4338931A (en) * | 1979-04-27 | 1982-07-13 | Claudio Cavazza | Device for the quick inhalation of drugs in powder form by humans suffering from asthma |
FR2454813A1 (en) * | 1979-04-27 | 1980-11-21 | Sigma Tau Ind Farmaceuti | DEVICE FOR RAPID INHALATION OF PHARMACEUTICAL POWDER PRODUCTS BY MAN |
GB2129691A (en) * | 1982-10-08 | 1984-05-23 | Glaxo Group Ltd | Devices for administering medicaments to patients |
GB2169265A (en) * | 1982-10-08 | 1986-07-09 | Glaxo Group Ltd | Pack for medicament |
US4627432A (en) * | 1982-10-08 | 1986-12-09 | Glaxo Group Limited | Devices for administering medicaments to patients |
US4778054A (en) * | 1982-10-08 | 1988-10-18 | Glaxo Group Limited | Pack for administering medicaments to patients |
GB2142246A (en) * | 1983-05-24 | 1985-01-16 | Glaxo Group Ltd | Medical administration devices |
GB2175865A (en) * | 1985-05-29 | 1986-12-10 | Stanwell Smith Colin Howard | Propellers for boats |
US4811731A (en) * | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
US5035237A (en) * | 1985-07-30 | 1991-07-30 | Newell Robert E | Devices for administering medicaments to patients |
US4995385A (en) * | 1989-02-23 | 1991-02-26 | Phidea S.P.A. | Inhaler with regular complete emptying of the capsule |
CA2020425A1 (en) * | 1989-07-04 | 1991-01-05 | Michel Brunet | Device for projecting a dose of divisible substance |
US5337740A (en) * | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
Non-Patent Citations (1)
Title |
---|
Product Literature, Lyphodose, of Valois. * |
Cited By (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5715810A (en) * | 1991-07-25 | 1998-02-10 | Sepracor Inc. | Inhalation devices |
US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US6729324B2 (en) | 1995-06-08 | 2004-05-04 | Innovative Devices, Llc. | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US20040237961A1 (en) * | 1995-06-08 | 2004-12-02 | Snow John Medlin | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US6561186B2 (en) | 1995-08-02 | 2003-05-13 | Innovative Devices | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US6550477B1 (en) * | 1995-08-02 | 2003-04-22 | Innovative Devices, Llc | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
US5794613A (en) * | 1997-01-09 | 1998-08-18 | Sepracor, Inc. | Multiple-dose dispenser for dry powder inhalers |
US6273085B1 (en) | 1997-03-20 | 2001-08-14 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6341605B1 (en) * | 1998-02-05 | 2002-01-29 | Unisia Jecs Corporation | Inhalant medicator |
US20050090798A1 (en) * | 1998-03-16 | 2005-04-28 | Andrew Clark | Aerosolized active agent delivery |
US6655379B2 (en) | 1998-03-16 | 2003-12-02 | Nektar Therapeutics | Aerosolized active agent delivery |
US6234459B1 (en) | 1998-03-18 | 2001-05-22 | Lytesyde, Llc | Medication processing system and method |
US6669176B2 (en) | 1998-03-18 | 2003-12-30 | Lytesyde, Llc | Medication processing system and method |
US6484715B1 (en) * | 1998-07-14 | 2002-11-26 | Ing. Erich Pfeiffer Gmbh | Media dispenser |
US20020168322A1 (en) * | 1998-10-09 | 2002-11-14 | Andrew Clark | Flow resistance modulated aerosolized active agent delivery |
US8408200B2 (en) | 1998-10-09 | 2013-04-02 | Novartis Ag | Flow resistance modulated aerosolized active agent delivery |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
US20050016533A1 (en) * | 1999-06-30 | 2005-01-27 | Inhale Therapeutic Systems | Systems and methods for aerosolizing pharmaceutical formulations |
US7318436B2 (en) | 2000-05-10 | 2008-01-15 | Innovative Devices, Llc | Medicament container with same side airflow inlet and outlet and method of use |
US20020134382A1 (en) * | 2000-05-10 | 2002-09-26 | Snow John M. | Medicament container with same side airflow inlet and outlet and method of use |
US20050056281A1 (en) * | 2000-05-10 | 2005-03-17 | Snow John M. | Medicament container with same side airflow inlet and outlet and method of use |
US6923178B2 (en) | 2000-05-10 | 2005-08-02 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet |
US6948494B1 (en) | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
US6655381B2 (en) | 2000-06-23 | 2003-12-02 | Ivax Corporation | Pre-metered dose magazine for breath-actuated dry powder inhaler |
GB2372215A (en) * | 2000-06-23 | 2002-08-21 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US20030015191A1 (en) * | 2001-04-26 | 2003-01-23 | New England Pharmaceuticals, Inc. | Metered dose delivery device for liquid and powder agents |
US7025058B2 (en) * | 2001-04-26 | 2006-04-11 | New England Pharmaceuticals, Inc. | Metered dose delivery device for liquid and powder agents |
US7185651B2 (en) | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
US20040000309A1 (en) * | 2002-06-18 | 2004-01-01 | William Alston | Flow regulator for aerosol drug delivery and methods |
US20070051362A1 (en) * | 2004-04-23 | 2007-03-08 | Sullivan Timothy R | Multiple unit dose drug delivery system |
US20080314384A1 (en) * | 2004-12-09 | 2008-12-25 | David Stuart Harris | Dry Powder Inhalers |
US8261739B2 (en) | 2004-12-09 | 2012-09-11 | Cambridge Consultants Limited | Dry powder inhalers |
US11491287B2 (en) * | 2005-07-20 | 2022-11-08 | Manta Devices, Llc | Inhalation device |
US20140216457A1 (en) * | 2005-07-20 | 2014-08-07 | Manta Devices, Llc | Inhalation device |
US10632268B2 (en) * | 2005-07-20 | 2020-04-28 | Manta Devices, Llc | Inhalation device |
US11672927B2 (en) * | 2005-07-20 | 2023-06-13 | Manta Devices, Llc | Inhalation device |
US9789270B2 (en) | 2005-08-16 | 2017-10-17 | Pari Pharma Gmbh | Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized |
US20090293868A1 (en) * | 2005-08-16 | 2009-12-03 | Pari Pharma Gmbh | Inhalation Therapy Device Comprising an Ampoule for Storing a Medicament To Be Nebulized |
US11278683B2 (en) | 2005-08-16 | 2022-03-22 | Pari Pharma Gmbh | Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized |
US20070169760A1 (en) * | 2006-01-23 | 2007-07-26 | Rock Kelly P | Fuel processor apparatus and method |
US7681569B2 (en) | 2006-01-23 | 2010-03-23 | Lytesyde, Llc | Medical liquid processor apparatus and method |
US20070169773A1 (en) * | 2006-01-23 | 2007-07-26 | Lytesyde, Llc | Medical liquid processor apparatus and method |
US7717096B2 (en) | 2006-01-23 | 2010-05-18 | Lytesyde, Llc | Fuel processor apparatus and method |
US20180087718A1 (en) * | 2006-11-27 | 2018-03-29 | Frank Levy | Disposable single-use cartridge for holding compressed medical gas |
US20160356427A1 (en) * | 2006-11-27 | 2016-12-08 | Frank Levy | Disposable cartridge for holding compressed medical gas |
US9446197B2 (en) | 2007-01-09 | 2016-09-20 | Mystic Pharmaceuticals, Inc. | Intranasal cartridge devices |
US8377009B2 (en) | 2007-01-09 | 2013-02-19 | Mystic Pharmaceuticals, Inc. | Intranasal cartridge devices |
US20080177246A1 (en) * | 2007-01-09 | 2008-07-24 | First City Tower | Intranasal Cartridge Devices |
US7669597B2 (en) | 2007-05-16 | 2010-03-02 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
US8683995B2 (en) | 2007-05-16 | 2014-04-01 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US9592354B2 (en) | 2007-05-16 | 2017-03-14 | Mystic Pharmaceuticals, Inc. | Combination unit dose dispensing containers |
US9248076B2 (en) | 2007-05-16 | 2016-02-02 | Mystic Pharmaceuticals, Inc. | Dose dispensing containers |
US11224704B2 (en) | 2007-07-06 | 2022-01-18 | Manta Devices, Llc | Dose delivery device for inhalation |
US9919115B2 (en) | 2007-07-06 | 2018-03-20 | Manta Devices, Llc | Dose delivery device for inhalation with first and second portions to open a dose chamber |
US20090038582A1 (en) * | 2007-08-07 | 2009-02-12 | Lytesyde, Llc | Fuel Processor Apparatus and Method |
US8028674B2 (en) | 2007-08-07 | 2011-10-04 | Lytesyde, Llc | Fuel processor apparatus and method |
US20090071108A1 (en) * | 2007-09-14 | 2009-03-19 | Mystic Pharmaceuticals, Inc. | Deep draw container forming method |
US7963089B2 (en) | 2007-09-14 | 2011-06-21 | Mystic Pharmaceuticals, Inc. | Deep draw container forming method |
US11077263B2 (en) | 2007-11-23 | 2021-08-03 | Pari Pharma Gmbh | Disposable ampoule for an aerosol generating device |
US20090137950A1 (en) * | 2007-11-23 | 2009-05-28 | Pari Pharma Gmbh | Disposable ampoule for an aerosol generating device |
US9265900B2 (en) | 2007-11-23 | 2016-02-23 | Pari Pharma Gmbh | Disposable ampoule for an aerosol generating device |
US20100078022A1 (en) * | 2008-09-26 | 2010-04-01 | Rachel Striebig | Inhalers with airway disks having discrete airway channels and related disks and methods |
US10493222B2 (en) | 2008-09-26 | 2019-12-03 | Oriel Therapeutics, Inc. | Dry powder dose container assemblies and related inhalers |
US20110162648A1 (en) * | 2008-09-26 | 2011-07-07 | Ruckdeschel Thomas W | Inhaler mechanisms with radially biased piercers and related methods |
US8985103B2 (en) | 2008-09-26 | 2015-03-24 | Oriel Therapeutics, Inc. | Dry powder inhalers with dual piercing members |
US8887722B2 (en) | 2008-09-26 | 2014-11-18 | Oriel Therapeutics, Inc. | Inhaler mechanisms with radially biased piercers and related methods |
US8671938B2 (en) | 2008-09-26 | 2014-03-18 | Oriel Therapeutics, Inc. | Inhalers with airway disks having discrete airway channels and related disks and methods |
US9597465B2 (en) | 2008-09-26 | 2017-03-21 | Oriel Therapeutics, Inc. | Methods of operating and fabricating inhalers with airway disks having discrete airway channels |
US8550071B2 (en) | 2008-09-26 | 2013-10-08 | Oriel Therapeutics, Inc. | Inhalers with airway disks having discrete airway channels and related disks and methods |
US9795749B2 (en) | 2008-09-26 | 2017-10-24 | Oriel Therapeutics, Inc. | Dry powder inhalers with dual piercing members and methods of operating same |
US8381721B2 (en) | 2008-09-26 | 2013-02-26 | Oriel Therapeutics, Inc. | Dry powder inhalers with dual piercing members and related devices and methods |
US20110174306A1 (en) * | 2008-09-30 | 2011-07-21 | David Harris | Dry Powder Inhalers with Multi-Facet Surface Deagglomeration Chambers and Related Devices and Methods |
US9050427B2 (en) | 2008-09-30 | 2015-06-09 | Oriel Therapeutics, Inc. | Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods |
US20110186047A1 (en) * | 2008-10-01 | 2011-08-04 | Scott Alexander Lewis | Dry Powder Inhalers with Rotating Piercing Mechanisms and Related Devices and Methods |
US8646446B2 (en) | 2008-10-01 | 2014-02-11 | Oriel Therapeutics, Inc. | Dry powder inhalers with rotating piercing mechanisms and related devices and methods |
USD684684S1 (en) | 2010-03-26 | 2013-06-18 | Oriel Therapeutics, Inc. | Dry powder inhaler |
USD685461S1 (en) | 2010-03-26 | 2013-07-02 | Oriel Therapeutics, Inc. | Dose disk for a dry powder inhaler |
USD711528S1 (en) | 2010-03-26 | 2014-08-19 | Oriel Therapeutics, Inc. | Dry powder inhaler |
USD745660S1 (en) | 2010-03-26 | 2015-12-15 | Oriel Therapeutics, Inc. | Dry powder inhaler |
USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
USD635246S1 (en) | 2010-03-26 | 2011-03-29 | Oriel Therapeutics, Inc. | Dose disk for dry powder inhalers |
US11147936B2 (en) | 2014-05-02 | 2021-10-19 | Manta Devices, Llc | Dose delivery device with cover connected to dose chamber seal |
US9861578B1 (en) * | 2017-05-11 | 2018-01-09 | Yuri Issac Busiashvili | Sublingual dosimetric drip caged ball valve device |
Also Published As
Publication number | Publication date |
---|---|
DK0525720T3 (en) | 1997-05-12 |
GR3022762T3 (en) | 1997-06-30 |
EP0525720A1 (en) | 1993-02-03 |
ATE146363T1 (en) | 1997-01-15 |
DE69215994T2 (en) | 1997-06-26 |
EP0525720B1 (en) | 1996-12-18 |
ES2097839T3 (en) | 1997-04-16 |
NO305852B1 (en) | 1999-08-09 |
NZ243649A (en) | 1995-06-27 |
ZA925718B (en) | 1994-02-28 |
AU665765B2 (en) | 1996-01-18 |
AU2038492A (en) | 1993-02-04 |
MX9204499A (en) | 1993-02-01 |
DE69215994D1 (en) | 1997-01-30 |
CA2075113A1 (en) | 1993-02-02 |
JPH07108316B2 (en) | 1995-11-22 |
US5715810A (en) | 1998-02-10 |
US5337740A (en) | 1994-08-16 |
JPH05192404A (en) | 1993-08-03 |
NO923016L (en) | 1993-02-02 |
FI923404A0 (en) | 1992-07-28 |
FI923404A (en) | 1993-02-02 |
NO923016D0 (en) | 1992-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5529059A (en) | Inhalation devices | |
CA2445516C (en) | Metered dose delivery device for liquid and powder agents | |
JP4195005B2 (en) | Powder inhaler | |
AU731677B2 (en) | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | |
AU749292B2 (en) | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament | |
EP0028162B1 (en) | Breath actuated devices for administering powdered medicaments | |
US4570630A (en) | Medicament inhalation device | |
US4098273A (en) | Inhalation device | |
JP4497730B2 (en) | Powder inhaler for complex drugs | |
EP0079478A1 (en) | Medicament inhalation device | |
JP2004526523A (en) | Inhalation device and method | |
US5988163A (en) | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament | |
IE41604B1 (en) | A device for the inhalation of medicaments | |
HU217896B (en) | Inhalation device | |
WO2009091780A2 (en) | Device for inhaling powdered medicaments | |
GB2061735A (en) | Breath actuated device for administration of powdered medicaments by inhalation | |
JP4163387B2 (en) | Powder inhaler | |
CZ290494A3 (en) | Inhalator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CC | Certificate of correction | ||
AS | Assignment |
Owner name: SEPRACOR INC., MASSACHUSETTS Free format text: MERGER;ASSIGNOR:NEW ENGLAND PHARMACEUTICALS, INC.;REEL/FRAME:008512/0744 Effective date: 19960703 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
LAPS | Lapse for failure to pay maintenance fees | ||
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20040625 |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |